BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, Shen J, Zhu LR, Chen Y, Iacucci M, Ng SC, Ghosh S, Chen MH. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020;5:667-78. [PMID: 32405603 DOI: 10.1016/S2468-1253(20)30126-6] [Cited by in Crossref: 543] [Cited by in F6Publishing: 639] [Article Influence: 181.0] [Reference Citation Analysis]
Number Citing Articles
1 Gupta T, Sharma H. COVID-19 and the liver: Are footprints still there? World J Gastroenterol 2023; 29(4): 656-669 [DOI: 10.3748/wjg.v29.i4.656] [Reference Citation Analysis]
2 Matsuda H, Nosaka T, Hiramatsu K, Takahashi K, Naito T, Ofuji K, Ohtani M, Imamura Y, Iwasaki H, Nakamoto Y. Histology and cytokine levels in hepatic injury accompanying a case of non-severe COVID-19. Clin J Gastroenterol 2023. [PMID: 36690911 DOI: 10.1007/s12328-023-01755-4] [Reference Citation Analysis]
3 Smirnova OA, Ivanova ON, Fedyakina IT, Yusubalieva GM, Baklaushev VP, Yanvarev DV, Kechko OI, Mitkevich VA, Vorobiev PO, Fedorov VS, Bartosch B, Valuev-elliston VT, Lipatova AL, Ivanov AV. SARS-CoV-2 Establishes a Productive Infection in Hepatoma and Glioblastoma Multiforme Cell Lines. Cancers 2023;15:632. [DOI: 10.3390/cancers15030632] [Reference Citation Analysis]
4 Khomeriki NM. The gastrointestinal tract is the gate of entrance for COVID-19. jour 2023. [DOI: 10.31146/1682-8658-ecg-206-10-152-156] [Reference Citation Analysis]
5 Catinean A, Sida A, Silvestru C, Balan GG. Ongoing Treatment with a Spore-Based Probiotic Containing Five Strains of Bacillus Improves Outcomes of Mild COVID-19. Nutrients 2023;15:488. [DOI: 10.3390/nu15030488] [Reference Citation Analysis]
6 Martin C, Obadeyi O, Yeo E, Tran D, Pak E. Pain Complaints and Intubation Risk in COVID-19: A Retrospective Cohort Study. Cureus 2023. [DOI: 10.7759/cureus.33851] [Reference Citation Analysis]
7 Baldelli L, Marjot T, Barnes E, Barritt AS, Webb GJ, Moon AM. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes. Gut Liver 2023;17:12-23. [PMID: 36457261 DOI: 10.5009/gnl220327] [Reference Citation Analysis]
8 Papagiouvanni I, Kotoulas SC, Pataka A, Spyratos DG, Porpodis K, Boutou AK, Papagiouvannis G, Grigoriou I, Vettas C, Goulis I. COVID-19 and liver injury: An ongoing challenge. World J Gastroenterol 2023; 29(2): 257-271 [DOI: 10.3748/wjg.v29.i2.257] [Reference Citation Analysis]
9 Basravi M, Shirani A, Mohammadi P, Seifi S. Mesanteric ischemia in a COVID-19 patient with no risk factors: A case report. Int J Surg Case Rep 2023;103:107891. [PMID: 36642027 DOI: 10.1016/j.ijscr.2023.107891] [Reference Citation Analysis]
10 Brandi N, Spinelli D, Granito A, Tovoli F, Piscaglia F, Golfieri R, Renzulli M. COVID-19: Has the Liver Been Spared? Int J Mol Sci 2023;24. [PMID: 36674607 DOI: 10.3390/ijms24021091] [Reference Citation Analysis]
11 Brock S, Jackson DB, Soldatos TG, Hornischer K, Schäfer A, Diella F, Emmert MY, Hoerstrup SP. Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms. Front Mol Med 2023;2. [DOI: 10.3389/fmmed.2022.1035290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Karime C, Travers P, Ouni A, Francis D. Association Between Coronavirus Disease 2019 and Acute Complicated Diverticulitis. Cureus 2023. [DOI: 10.7759/cureus.33252] [Reference Citation Analysis]
13 Szpulak A, Garlak U, Ćwirko H, Witkowska B, Rombel-Bryzek A, Witkowska D. SARS-CoV-2 and its impact on the cardiovascular and digestive systems - The interplay between new virus variants and human cells. Comput Struct Biotechnol J 2023;21:1022-9. [PMID: 36694807 DOI: 10.1016/j.csbj.2023.01.024] [Reference Citation Analysis]
14 Deng H, Mai Y, Liu H, Guan J. Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients. Ann Hepatol 2023;28:100763. [PMID: 36182032 DOI: 10.1016/j.aohep.2022.100763] [Reference Citation Analysis]
15 Bao J, Liu S, Liang X, Wang C, Cao L, Li Z, Wei F, Fu A, Shi Y, Shen B, Zhu X, Zhao Y, Liu H, Miao L, Wang Y, Liang S, Wu L, Huang J, Guo T, Liu F. A prediction model for COVID-19 liver dysfunction in patients with normal hepatic biochemical parameters. Life Sci Alliance 2023;6:e202201576. [PMID: 36261228 DOI: 10.26508/lsa.202201576] [Reference Citation Analysis]
16 Siyal M, Abbas Z, Ashraf J, Ali Qadeer M, Altaf A. Incidence and predisposing factors for de novo post-COVID-19 irritable bowel syndrome. Eur J Gastroenterol Hepatol 2023;35:59-63. [PMID: 36468570 DOI: 10.1097/MEG.0000000000002475] [Reference Citation Analysis]
17 Özden Ö, Lafli Tunay D. The Relationship Between COVID-19 Related Coagulopathy with Organ Damage and Prognosis. JoCASS 2022;5:342-350. [DOI: 10.36516/jocass.1174534] [Reference Citation Analysis]
18 Jia L, Weng S, Wu J, Tian X, Zhang Y, Wang X, Wang J, Yan D, Wang W, Fang F, Zhu Z, Qiu C, Zhang W, Xu Y, Wan Y. Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity. Gut Microbes 2022;14:2117503. [DOI: 10.1080/19490976.2022.2117503] [Reference Citation Analysis]
19 Malden DE, Tartof SY, Ackerson BK, Hong V, Skarbinski J, Yau V, Qian L, Fischer H, Shaw SF, Caparosa S, Xie F. Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System. JMIR Public Health Surveill 2022;8:e41529. [PMID: 36446133 DOI: 10.2196/41529] [Reference Citation Analysis]
20 Yao Y, Liu ZJ, Zhang YK, Sun HJ. Mechanism and potential treatments for gastrointestinal dysfunction in patients with COVID-19. World J Gastroenterol 2022; 28(48): 6811-6826 [DOI: 10.3748/wjg.v28.i48.6811] [Reference Citation Analysis]
21 Tews HC, Kandulski A, Schmid S, Schlosser S, Schirner S, Putz FJ, Cosma L, Gülow K, Müller M, Jung EM. Multimodal ultrasound imaging with conventional B-mode, elastography, and parametric analysis of contrast-enhanced ultrasound (CEUS): A novel approach to assess small bowel manifestation in severe COVID-19 disease. Clin Hemorheol Microcirc 2022;82:341-60. [PMID: 35871323 DOI: 10.3233/CH-221540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Jia FJ, Han J. Liver injury in COVID-19: Holds ferritinophagy-mediated ferroptosis accountable. World J Clin Cases 2022; 10(36): 13148-13156 [DOI: 10.12998/wjcc.v10.i36.13148] [Reference Citation Analysis]
23 Ohuabunwa U, Afolabi P, Tom-Aba D, Fluker SA. Clinical presentation of COVID-19 and association with outcomes among hospitalized older adults. J Am Geriatr Soc 2022. [PMID: 36565152 DOI: 10.1111/jgs.18163] [Reference Citation Analysis]
24 Hu WS, Jiang FY, Shu W, Zhao R, Cao JM, Wang DP. Liver injury in COVID-19: A minireview. World J Gastroenterol 2022; 28(47): 6716-6731 [DOI: 10.3748/wjg.v28.i47.6716] [Reference Citation Analysis]
25 Polyzogopoulou E, Amoiridou P, Abraham TP, Ventoulis I. Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review. World J Gastroenterol 2022; 28(47): 6662-6688 [DOI: 10.3748/wjg.v28.i47.6662] [Reference Citation Analysis]
26 Bernal-Utrera C, Montero-Almagro G, Anarte-Lazo E, Gonzalez-Gerez JJ, Rodriguez-Blanco C, Saavedra-Hernandez M. Therapeutic Exercise Interventions through Telerehabilitation in Patients with Post COVID-19 Symptoms: A Systematic Review. J Clin Med 2022;11. [PMID: 36556137 DOI: 10.3390/jcm11247521] [Reference Citation Analysis]
27 Kazuki Maegawa, Hiroaki Nishioka. COVID-19-associated parotitis and sublingual gland sialadenitis. BMJ Case Rep 2022;15:e251730. [PMID: 36535731 DOI: 10.1136/bcr-2022-251730] [Reference Citation Analysis]
28 Gao Q, Yin X, Tan B, Wang J, Chen J, Zhao B, Yang Q, Li Z. Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019. BMC Infect Dis 2022;22:929. [PMID: 36503381 DOI: 10.1186/s12879-022-07896-0] [Reference Citation Analysis]
29 He S, Wu K, Cheng Z, He M, Hu R, Fan N, Shen L, Li Q, Fan H, Tong Y. Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions. MedComm 2022;3. [DOI: 10.1002/mco2.196] [Reference Citation Analysis]
30 Saha L, Vij S, Rawat K. Liver injury induced by COVID 19 treatment – what do we know? World J Gastroenterol 2022; 28(45): 6314-6327 [DOI: 10.3748/wjg.v28.i45.6314] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Casalini G, Giacomelli A, Antinori S. Liver tests abnormalities with licensed antiviral drugs for COVID-19: a narrative review. Expert Opin Drug Saf 2022;21:1483-94. [PMID: 36597859 DOI: 10.1080/14740338.2022.2160446] [Reference Citation Analysis]
32 Tang S, Zhang F, Liu Q, Li L. Corona virus disease 2019-associated liver injury in cold regions. Frigid Zone Medicine 2022;2:193-199. [DOI: 10.2478/fzm-2022-0026] [Reference Citation Analysis]
33 Paula SM, Saraiva LGM, Dayllanna Stefanny Lopes Lima Feitosa, Silva RRDC, Borges IC, Araújo DV, Marinho SS, Souza MÂNE, Souza MHLP. Bowel symptoms associated with coronavirus disease 19 in hospitalized patients with moderate to severe illness. Int J Innov Educ Res 2022;10:94-105. [DOI: 10.31686/ijier.vol10.iss12.4011] [Reference Citation Analysis]
34 Vaman RS, Valamparampil MJ, Varghese B, Mathews E, Kunhiraman M, Ramachandran R. Association of symptom characteristics and comorbid conditions with viral RNA positivity of Covid-19 patients in Kasaragod district in Kerala, India: A retrospective cohort study. NMJI 2022;35:138-141. [DOI: 10.25259/nmji-35-3-138] [Reference Citation Analysis]
35 Cuicchi D, Gabrielli L, Tardio ML, Rossini G, D’Errico A, Viale P, Lazzarotto T, Poggioli G. Virological and histological evaluation of intestinal samples in COVID-19 patients. World J Gastroenterol 2022; 28(44): 6282-6293 [DOI: 10.3748/wjg.v28.i44.6282] [Reference Citation Analysis]
36 Li X, Wang W, Yan S, Zhao W, Xiong H, Bao C, Chen J, Yue Y, Su Y, Zhang C. Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1019487] [Reference Citation Analysis]
37 Wongtanasarasin W. Cholestatic liver injury: A rare but fatal complication during and after COVID-19 infection. World J Virol 2022; 11(6): 435-442 [DOI: 10.5501/wjv.v11.i6.435] [Reference Citation Analysis]
38 Chen X, Hong J, Li Y, An C, Guo J, Yang J. Case report: Severe acute hepatitis in a 22-month-old Chinese boy with Omicron sub-variant BA.2.38. Front Public Health 2022;10:1012638. [PMID: 36504992 DOI: 10.3389/fpubh.2022.1012638] [Reference Citation Analysis]
39 Maev IV, Andreev DN, Sokolov PS, Fomenko AК, Devkota MK, Andreev NG, Zaborovsky AV. Efficacy of <i>Saccharomyces boulardii</i> CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19. Terapevticheskii arkhiv 2022;94:1163-1170. [DOI: 10.26442/00403660.2022.10.201881] [Reference Citation Analysis]
40 Grigoriev KI, Kharitonova LA. COVID-19 and the digestive system lesions in children. Ross vestn perinatol pediatr 2022;67:6-17. [DOI: 10.21508/1027-4065-2022-67-5-6-17] [Reference Citation Analysis]
41 Ahmed GK, Salman SA, Elbeh K, Amer ZS, Abbas AM. Correlation between psychiatric impact of COVID-19 during pregnancy and fetal outcomes in Egyptian women. Psychiatry Research 2022;317:114920. [DOI: 10.1016/j.psychres.2022.114920] [Reference Citation Analysis]
42 Krenytska D, Kot L, Halenova T, Raksha N, Vovk T, Savchuk O, Pellicano R, Abenavoli L, Falalyeyeva T, Ostapchenko L. Cytokine profile in patients with osteoarthritis after SARS-CoV-2 infection. Minerva Biotechnol Biomol Res 2022;34. [DOI: 10.23736/s2724-542x.22.02943-1] [Reference Citation Analysis]
43 Dufour JF, Marjot T, Becchetti C, Tilg H. COVID-19 and liver disease. Gut 2022;71:2350-62. [PMID: 35701093 DOI: 10.1136/gutjnl-2021-326792] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
44 Rosso C, Demelas C, Agostini G, Abate ML, Vernero M, Caviglia GP, D’amato D, Armandi A, Tapparo M, Guariglia M, Troshina G, Massano A, Olivero A, Nicolosi A, Zannetti A, Pellicano R, Ciancio A, Saracco GM, Ribaldone DG, Bugianesi E, Fagoonee S. Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis. Viruses 2022;14:2397. [DOI: 10.3390/v14112397] [Reference Citation Analysis]
45 Salari N, Khodayari Y, Hosseinian-far A, Zarei H, Rasoulpoor S, Akbari H, Mohammadi M. Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis. BioPsychoSocial Med 2022;16. [DOI: 10.1186/s13030-022-00250-5] [Reference Citation Analysis]
46 Zhang F, Lau RI, Liu Q, Su Q, Chan FKL, Ng SC. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat Rev Gastroenterol Hepatol 2022;:1-15. [PMID: 36271144 DOI: 10.1038/s41575-022-00698-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Wu HHL, Athwal VS, Kalra PA, Chinnadurai R. COVID-19 and hepatorenal syndrome. World J Gastroenterol 2022; 28(39): 5666-5678 [DOI: 10.3748/wjg.v28.i39.5666] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Chen D, Ning M, Feng Y, Liu J. The early stage of COVID-19 pandemic: Gastrointestinal manifestations and liver injury in COVID-19 patients in Wuhan, China. Front Med 2022;9:997000. [DOI: 10.3389/fmed.2022.997000] [Reference Citation Analysis]
49 Xu Z, Zou Y, Gao X, Niu M, Li J, Xue L, Jiang S. Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection. Front Pharmacol 2022;13:1041331. [DOI: 10.3389/fphar.2022.1041331] [Reference Citation Analysis]
50 Soe AM, Aung KKK, Shan MA, San PE, Lin KK, Thu SP. Outcome of COVID-19 Patients Presented with Gastrointestinal and Hepatic Manifestations. GastroHep 2022;2022:1-9. [DOI: 10.1155/2022/3615619] [Reference Citation Analysis]
51 Cárdenas-Jaén K, Sánchez-Luna SA, Vaillo-Rocamora A, Castro-Zocchi MR, Guberna-Blanco L, Useros-Brañas D, Remes-Troche JM, Medina AR, Priego-Parra BA, Velarde-Ruiz Velasco JA, Martínez-Ayala P, Urzúa Á, Guiñez-Francois D, Pawlak KM, Kozłowska-Petriczko K, Gorroño-Zamalloa I, Urteaga-Casares C, Ortiz-Polo I, Antoñana ADV, Lozada-Hernández EE, Obregón-Moreno E, García-Rayado G, Domper-Arnal MJ, Casas-Deza D, Esteban-Cabello EI, Díaz LA, Riquelme A, Martínez-Lozano H, Navarro-Romero F, Olivas I, Iborra-Muñoz G, Calero-Amaro A, Caravaca-García I, Lacueva-Gómez FJ, Pastor-Mateu R, Lapeña-Muñoz B, Sastre-Lozano V, Pizarro-Vega NM, Melcarne L, Pedrosa-Aragón M, Mira JJ, MStat AM, Carrillo I, de-Madaria E. Gastrointestinal symptoms and complications in patients hospitalized due to COVID-19, an international multicentre prospective cohort study (TIVURON project). Gastroenterol Hepatol 2022:S0210-5705(22)00233-3. [PMID: 36243249 DOI: 10.1016/j.gastrohep.2022.10.007] [Reference Citation Analysis]
52 Lukmanova AM, Isanbaeva AR, Sakhautdinova GM. Cytolytic syndrome in patients with COVID-19. jour 2022. [DOI: 10.31146/1682-8658-ecg-203-7-115-122] [Reference Citation Analysis]
53 Abdulganieva DI, Mukhametova DD, Shamsutdinova NG, Galieva AM. Abnormal liver function tests in patients with COVID-19. jour 2022. [DOI: 10.31146/1682-8658-ecg-203-7-123-130] [Reference Citation Analysis]
54 Levitan BN, Skvortsov VV, Eremenko NV. Extrapulmonary manifestations of SARS-CoV-2: a new coronavirus infectionas an aggravating factor in peptic ulcer disease. jour 2022. [DOI: 10.31146/1682-8658-ecg-199-3-134-142] [Reference Citation Analysis]
55 Fomina LA, Nemirov KE, Sacharova EM. Gastroenterological manifestations of SARS-CoV-2 and possible consequences of the infection. jour 2022. [DOI: 10.31146/1682-8658-ecg-200-4-9-13] [Reference Citation Analysis]
56 Marjot T, Eberhardt CS, Boettler T, Belli LS, Berenguer M, Buti M, Jalan R, Mondelli MU, Moreau R, Shouval D, Berg T, Cornberg M. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper. J Hepatol 2022;77:1161-97. [PMID: 35868584 DOI: 10.1016/j.jhep.2022.07.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
57 Schwarz S, Lang C, Harlander M, Štupnik T, Slambrouck JV, Ceulemans LJ, Ius F, Gottlieb J, Kuhnert S, Hecker M, Aigner C, Kneidinger N, Verschuuren EA, Smits JM, Tschernko E, Schaden E, Faybik P, Markstaller K, Trauner M, Jaksch P, Hoetzenecker K. Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS. J Heart Lung Transplant 2022;41:1501-10. [PMID: 35907758 DOI: 10.1016/j.healun.2022.06.020] [Reference Citation Analysis]
58 Torrinhas RS, Ribeiro PC, Syagha Y, Coradelli ACP, Miguel BZB, Freire TN, da Silva MAR, Ruotolo F, de Almeida DH, Buzato JN, E Silva HO, Martinez AC, Dias MCG, Waitzberg DL. Gastrointestinal and sensory manifestations, nutrition management, and energy-protein intake in hospitalized patients with COVID-19. Nutr Clin Pract 2022;37:1152-61. [PMID: 36073835 DOI: 10.1002/ncp.10906] [Reference Citation Analysis]
59 Mojahed N, Mohammadkhani MA, Pourasgari M, Gol-jah Rad G, Mohamadkhani A. Viral Gastroenteritis Prevalence in Iranian Pediatric Population: A Systematic Review. Avicenna J Clin Microbiol Infect 2022;9:124-129. [DOI: 10.34172/ajcmi.2022.3389] [Reference Citation Analysis]
60 Brisinda G, Chiarello MM, Tropeano G, Altieri G, Puccioni C, Fransvea P, Bianchi V. SARS-CoV-2 and the pancreas: What do we know about acute pancreatitis in COVID-19 positive patients? World J Gastroenterol 2022; 28(36): 5240-5249 [DOI: 10.3748/wjg.v28.i36.5240] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Clerbaux L, Mayasich SA, Muñoz A, Soares H, Petrillo M, Albertini MC, Lanthier N, Grenga L, Amorim M. Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. JCM 2022;11:5691. [DOI: 10.3390/jcm11195691] [Reference Citation Analysis]
62 Kroepfl V, Treml B, Freund MC, Profanter C. Early detection of COVID-19 cholangiopathy using cholangioscopy—a case report of two critically ill patients. Eur Surg 2022. [DOI: 10.1007/s10353-022-00776-6] [Reference Citation Analysis]
63 Rajamanickam K, Rathinavel T, Periyannan V, Ammashi S, Marimuthu S, Nasir Iqbal M. Molecular insight of phytocompounds from Indian spices and its hyaluronic acid conjugates to block SARS-CoV-2 viral entry. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2121757] [Reference Citation Analysis]
64 Gao Q, Yin X, Tan B, Wang J, Chen J, Yang Q, Zhao B, Li Z. Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019.. [DOI: 10.21203/rs.3.rs-1986289/v1] [Reference Citation Analysis]
65 Meshcheryakova A, Zimmermann P, Salzmann M, Pietschmann P, Mechtcheriakova D. Singularity and Commonality in Response to SARS-CoV-2 in Lung and Colon Cell Models. Int J Mol Sci 2022;23:10451. [PMID: 36142362 DOI: 10.3390/ijms231810451] [Reference Citation Analysis]
66 Masanam MK, Cheney SM, Sutton W, Keyloun JW, Fitzgibbons S. COVID-19 infection and large intestinal perforation: A case series. International Journal of Surgery Case Reports 2022;98:107538. [DOI: 10.1016/j.ijscr.2022.107538] [Reference Citation Analysis]
67 Sayed IA, Bhalala U, Strom L, Tripathi S, Kim JS, Michaud K, Chiotos K, Dapul HR, Gharpure VP, Bjornstad EC, Heneghan JA, Irby K, Montgomery V, Gupta N, Gupta M, Boman K, Bansal V, Kashyap R, Walkey AJ, Kumar VK, Gist KM, on behalf of the VIRUS Investigators. Gastrointestinal Manifestations in Hospitalized Children With Acute SARS-CoV-2 Infection and Multisystem Inflammatory Condition: An Analysis of the VIRUS COVID-19 Registry. Pediatric Infectious Disease Journal 2022;41:751-758. [DOI: 10.1097/inf.0000000000003589] [Reference Citation Analysis]
68 Naghmeh Moslehi, Mahsa Hadipour Jahromy, Pegah Ashrafi, Kimia Vatani, Mohammad A. H. Nemati, Parnian A. Moghadam, Fatemeh Rostamian, Mana H. Jahromi. Multi-organ system involvement in coronavirus disease 2019 (COVID-19): A mega review. J Family Med Prim Care 2022;11. [PMID: 36505634 DOI: 10.4103/jfmpc.jfmpc_1570_21] [Reference Citation Analysis]
69 Prasad KT. COVID-19 and Pulmonary Diseases. COVID-19: Effects in Comorbidities and Special Populations 2022. [DOI: 10.2174/9789815036367122010010] [Reference Citation Analysis]
70 Fleagle J, Xiao W, Cottam M, Lorch M. Oral Complaint Visits to the Pediatric Emergency Department During the COVID-19 Pandemic. Cureus 2022. [DOI: 10.7759/cureus.28559] [Reference Citation Analysis]
71 Zaman S, Hajibandeh S, Hajibandeh S, Mohamedahmed AYY, El‐asrag ME, Quraishi N, Iqbal TH, Beggs AD. Meta‐analysis of the demographic and prognostic significance of gastrointestinal symptoms in COVID ‐19 patients. JGH Open 2022. [DOI: 10.1002/jgh3.12812] [Reference Citation Analysis]
72 Balaphas A, Gkoufa K, Colucci N, Perdikis KC, Gaudet-Blavignac C, Pataky Z, Carballo S, Ris F, Stirnemann J, Lovis C, Goossens N, Toso C. Abdominal pain patterns during COVID-19: an observational study. Sci Rep 2022;12:14677. [PMID: 36038578 DOI: 10.1038/s41598-022-18753-0] [Reference Citation Analysis]
73 Madan K, Rudresh HK, Rao A, Sandeep S, Monica N, Gupta A. Clues from the Pandora's Box: Frequency of Acute Abdominal Symptoms in COVID-19 and Its Association with Inflammatory Markers-a Cross-Sectional Study. Indian J Surg 2022;:1-6. [PMID: 36033378 DOI: 10.1007/s12262-022-03550-w] [Reference Citation Analysis]
74 Zasadzka E, Tobis S, Trzmiel T, Marchewka R, Kozak D, Roksela A, Pieczyńska A, Hojan K. Application of an EMG-Rehabilitation Robot in Patients with Post-Coronavirus Fatigue Syndrome (COVID-19)-A Feasibility Study. Int J Environ Res Public Health 2022;19:10398. [PMID: 36012033 DOI: 10.3390/ijerph191610398] [Reference Citation Analysis]
75 Aktaş E, Özdemir Özgentürk N. Revealing In Silico that Bacteria's Outer Membrane Proteins may Help our Bodies Replicate and Carry Severe Acute Respiratory Syndrome Coronavirus 2. Bioinform Biol Insights 2022;16:11779322221116320. [PMID: 35966808 DOI: 10.1177/11779322221116320] [Reference Citation Analysis]
76 Aquino-matus J, Uribe M, Chavez-tapia N. COVID-19: Current Status in Gastrointestinal, Hepatic, and Pancreatic Diseases—A Concise Review. TropicalMed 2022;7:187. [DOI: 10.3390/tropicalmed7080187] [Reference Citation Analysis]
77 Chelombitko EG, Federal State Budgetary Institution «Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies» of the Federal Medical and Biological Agency of the Russian Federation, Moscow, Russia, Gusakova EV, Nagornev SN, Frolkov VK, FSBI FPE Central State Medical Academy of the Administration of the President of the Russian Federation, Moscow, Russia, Federal State Budgetary Institution «Center for Strategic Planning and Management of Medical and Biological Health Risks» of the Federal Medical and Biological Agency of the Russian Federation, Moscow, Russia, Federal State Budgetary Institution «Center for Strategic Planning and Management of Medical and Biological Health Risks» of the Federal Medical and Biological Agency of the Russian Federation, Moscow, Russia. Initial clinical and functional status of patients with post-covid syndrome and the efficiency of non-drug rehabilitation methods. Physiotherapist 2022. [DOI: 10.33920/med-14-2208-05] [Reference Citation Analysis]
78 Baykal H, Çelik D, Bulut S, Kurt HG, Ülger AF. Loss of smell in COVID-19 patients: is it related to clinical-radiological disease severity? Anatolian Curr Med J / ACMJ / acmj 2022;4:228-233. [DOI: 10.38053/acmj.1065354] [Reference Citation Analysis]
79 Frolova IA, Tarlovskaya EI, Romanov SV. Comparative analysis of the course and outcomes of a new coronavirus infection depending on the level of high-density lipoproteins in hospitalized patients with COVID-19. jour 2022;18:117-128. [DOI: 10.52727/2078-256x-2022-18-2-117-128] [Reference Citation Analysis]
80 Yousaf K, Toffaha A, Yasin ALF, Al Naimi N, Ahmed A, Abu Nada M, Yousif M, Parvaiz A. A Rare Case of COVID-19 Infection Leading to Colonic Stricture: Case Report and Review of Literature. Cureus 2022. [DOI: 10.7759/cureus.27043] [Reference Citation Analysis]
81 Pichugina IM, Ogoltsova IM. Jaundice as an atypical manifestation of the new coronavirus infection. Case report. Consilium Medicum 2022;24:343-348. [DOI: 10.26442/20751753.2022.5.201538] [Reference Citation Analysis]
82 Jaramillo-esparza CM, Vázquez-frias R. Risk of pediatric inflammatory multi-system syndrome (PIMS or MIS-C) in pediatric patients with COVID-19 presenting with gastrointestinal symptoms. Front Pediatr 2022;10:904793. [DOI: 10.3389/fped.2022.904793] [Reference Citation Analysis]
83 Arnaboldi S, Mangeri L, Galuppini E, Righi F, Tilola M, Scarazzato A, Bertasi B, Finazzi G, Varisco G, Filipello V, Losio M. Is SARS-CoV-2 a Concern for Food Safety? A Very Low Prevalence from a Food Survey during the COVID-19 Pandemic in Northern Italy. Foods 2022;11:2096. [DOI: 10.3390/foods11142096] [Reference Citation Analysis]
84 Ailioaie LM, Ailioaie C, Litscher G, Chiran DA. Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic. IJMS 2022;23:7719. [DOI: 10.3390/ijms23147719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Cruz GA, Pott-junior H, Gregorio JP, Liberato ELA, Slywitch Filho G, Boteon TB, dos Santos SDS, Rizzatti FPG, Anibal FDF, Roscani MG. The role of biomarkers in the prediction of mortality in hospitalized patients for COVID-19. F1000Res 2022;11:753. [DOI: 10.12688/f1000research.123223.1] [Reference Citation Analysis]
86 Golla R, Vuyyuru SK, Kante B, Kedia S, Ahuja V. Disorders of gut-brain interaction in post-acute COVID-19 syndrome. Postgrad Med J 2022:postgradmedj-2022-141749. [PMID: 35777934 DOI: 10.1136/pmj-2022-141749] [Reference Citation Analysis]
87 Rasmi Y, Hatamkhani S, Naderi R, Shokati A, Nayeb Zadeh V, Hosseinzadeh F, Farnamian Y, Jalali L. Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection. Acta Histochem 2022;124:151908. [PMID: 35662001 DOI: 10.1016/j.acthis.2022.151908] [Reference Citation Analysis]
88 Targoński R, Gąsecka A, Prowancki A, Targoński R. An alternative to airborne droplet transmission route of SARS-CoV-2, the feco-oral route, as a factor shaping COVID-19 pandemic. Medical Hypotheses 2022. [DOI: 10.1016/j.mehy.2022.110903] [Reference Citation Analysis]
89 Qanneta R, Feliu-masgoret M, García-pardo G, Marimon-cortés F. Reactive ileal lymphoid hyperplasia related to SARS-CoV-2 infection as a unique clinical feature resembling Crohn’s disease. Revista de Gastroenterología de México (English Edition) 2022. [DOI: 10.1016/j.rgmxen.2022.07.010] [Reference Citation Analysis]
90 Negro A, Villa G, Rolandi S, Lucchini A, Bambi S. Gastrointestinal Bleeding in COVID-19 Patients. Gastroenterology Nursing 2022;45:267-275. [DOI: 10.1097/sga.0000000000000676] [Reference Citation Analysis]
91 Chandra S, Narang A, Choudhuri P, Gupta K. COVID 19: Airway Management and Pharmacological Strategies. Journal of Cardiac Critical Care TSS 2022;06:210-215. [DOI: 10.1055/s-0042-1759862] [Reference Citation Analysis]
92 Jamali A, Nemovi K, Bayraktutar BN, Farzaneh A, Chan K, Ramirez C, Shahkamrani E, Perumbeti A. Acute Pancreatitis in Individuals with COVID-19: A Case Report and Critical Review of Literature. Case Rep Med 2022;2022:1275287. [PMID: 35761951 DOI: 10.1155/2022/1275287] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Milano A, Efthymakis K, D'Ardes D, Tana M, Mazzotta E, De Febis G, Laterza F, Tarquini P, Marini E, Porreca E, Cipollone F, Neri M. Gastrointestinal manifestations of SARS-CoV-2 infection in an Italian population of hospitalized patients. Therap Adv Gastroenterol 2022;15:17562848221104610. [PMID: 35757382 DOI: 10.1177/17562848221104610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Sahu T, Pande B, PL M, Verma HK. Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity. World J Hepatol 2022; 14(6): 1099-1110 [DOI: 10.4254/wjh.v14.i6.1099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Canillas L, Broquetas T, Carrión JA, Pagano G, Soriano A, Garrido E, Fernández R, Viu A, Romero J, Díaz G, Cañete N, Coll S, Naranjo D, Bessa X, Garcia-Retortillo M, Puigvehí M. Follow-up evaluation of patients with liver test abnormalities detected during SARS-CoV2 infection. J Viral Hepat 2022;29:823-34. [PMID: 35708160 DOI: 10.1111/jvh.13718] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
96 Yang T, Yan MZ, Li X, Lau EHY. Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis. Infection 2022. [PMID: 35750943 DOI: 10.1007/s15010-022-01862-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Rabaan AA, Bakhrebah MA, Mutair AA, Alhumaid S, Al-jishi JM, Alsihati J, Albayat H, Alsheheri A, Aljeldah M, Garout M, Alfouzan WA, Alhashem YN, Albahrani S, Alshamrani SA, Alotaibi S, Alramadhan AA, Albasha HN, Hajissa K, Temsah M. Systematic Review on Pathophysiological Complications in Severe COVID-19 among the Non-Vaccinated and Vaccinated Population. Vaccines 2022;10:985. [DOI: 10.3390/vaccines10070985] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
98 Carmona-Torre F, Mínguez-Olaondo A, López-Bravo A, Tijero B, Grozeva V, Walcker M, Azkune-Galparsoro H, López de Munain A, Alcaide AB, Quiroga J, Del Pozo JL, Gómez-Esteban JC. Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies. Front Neurol 2022;13:886609. [PMID: 35720084 DOI: 10.3389/fneur.2022.886609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
99 González-Islas D, Sánchez-Moreno C, Orea-Tejeda A, Hernández-López S, Salgado-Fernández F, Keirns-Davis C, Galicia-Amor S, Trejo-Mellado E, Gochicoa-Rangel L, Castorena-Maldonado A. Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections. BMC Pulm Med 2022;22:223. [PMID: 35676657 DOI: 10.1186/s12890-022-02014-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Qanneta R, Feliu-masgoret M, García-pardo G, Marimon-cortés F. Hiperplasia linfoide ileal reactiva relacionada con infección por SARS-CoV-2 como característica clínica singular parecida a la enfermedad de Crohn. Revista de Gastroenterología de México 2022. [DOI: 10.1016/j.rgmx.2022.05.006] [Reference Citation Analysis]
101 Fujiyoshi S, Kakisaka T, Matsuzawa F, Shimokuni T, Kii S, Kuratani Y, Nishikawa M, Morita R, Nakanishi K, Takagi T, Takahashi M. Curative Liver Resection in a Case of Cecum Cancer Liver Metastasis after Coronavirus Disease-19 Following Percutaneous Transhepatic Portal Vein Embolization. Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi 2022;55:389-398. [DOI: 10.5833/jjgs.2021.0112] [Reference Citation Analysis]
102 Kaiyasah H, Fardan H, Bashir O, Hussein M, Alsubbah H, Dabal LA. Hepatic and gastrointestinal manifestations in patients with COVID-19 and relationship with disease severity: a single-centre experience. IJID Regions 2022;3:143-149. [DOI: 10.1016/j.ijregi.2022.03.025] [Reference Citation Analysis]
103 Săbiescu DM, Kamal AM, Kamal CK, Alexandru DO, Mitruț P. Liver damage in the context of SARS-CoV-2. Covid-19 treatment and its effects on the liver. J Med Life 2022;15:727-34. [PMID: 35928369 DOI: 10.25122/jml-2022-0177] [Reference Citation Analysis]
104 Kiyak M, Düzenli T. Lipase elevation on admission predicts worse clinical outcomes in patients with COVID-19. Pancreatology 2022;22:665-70. [PMID: 35537935 DOI: 10.1016/j.pan.2022.04.012] [Reference Citation Analysis]
105 Chen T, Hsu M, Lee M, Chou C. Gastrointestinal Involvement in SARS-CoV-2 Infection. Viruses 2022;14:1188. [DOI: 10.3390/v14061188] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
106 Sood A, Bedi O. Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications. Inflammopharmacology 2022. [PMID: 35637319 DOI: 10.1007/s10787-022-00999-9] [Reference Citation Analysis]
107 Zyoud SH, Al-Jabi SW, Shahwan MJ, Jairoun AA. Global research production pertaining to gastrointestinal involvement in COVID-19: A bibliometric and visualised study. World J Gastrointest Surg 2022; 14(5): 494-505 [DOI: 10.4240/wjgs.v14.i5.494] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Shahrokh S, Baradaran Ghavami S, Asadzadeh Aghdaei H, Parigi TL, Farmani M, Danese S, Ebrahimi Daryani N, Vossoughinia H, Balaii H, Alborzi F, Khoramjoo SM, Khanabadi B, Seyed Salehi A, Bastani A, Sharifi M, Safari MT, Malekpour H, Sherkat G, Saberafsharian M, Miri MB, Moosavi SH, Anaraki F, Nazemalhosseini-Mojarad E, Mohebi SR, Shojaie S, Pourhoseingholi MA, Zali MR. High prevalence of SARS-Coronavirus-2 in patients with inflammatory bowel disease and the role of soluble angiotensin converting Enzyme2. Arch Physiol Biochem 2022;:1-8. [PMID: 35617972 DOI: 10.1080/13813455.2022.2080228] [Reference Citation Analysis]
109 Orlova NV, Nikiforov VV. An integrated approach to the differential diagnosis of COVID-19 syndromes and symptoms. Epidemiology and Infectious Diseases 2022;26:44-56. [DOI: 10.17816/eid106168] [Reference Citation Analysis]
110 Yang S, Tong Y, Chen L, Yu W. Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19. Mol Biomed 2022;3:15. [PMID: 35593963 DOI: 10.1186/s43556-022-00077-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Mitrovic M, Tadic B, Jankovic A, Rankovic I, Kovac JD. Fatal gastrointestinal bleeding associated with acute pancreatitis as a complication of Covid-19: a case report. J Int Med Res 2022;50:3000605221098179. [PMID: 35538708 DOI: 10.1177/03000605221098179] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Zhou Y, Ge Y, Yang X, Cai Q, Ding Y, Hu L, Lu G. Prevalence and Outcomes of Pancreatic Enzymes Elevation in Patients With COVID-19: A Meta-Analysis and Systematic Review. Front Public Health 2022;10:865855. [DOI: 10.3389/fpubh.2022.865855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Harouachi A, Bouhout T, Hadj Kacem H, Serji B, Berkhli H, Madani H, El Harroudi T. Acute hepatitis with portal and mesenteric vein thrombosis revealing SARS-CoV-2 infection: Case report and literature review. Ann Med Surg (Lond) 2022;77:103706. [PMID: 35531429 DOI: 10.1016/j.amsu.2022.103706] [Reference Citation Analysis]
114 Ippolito D, Vernuccio F, Maino C, Cannella R, Giandola T, Ragusi M, Bigiogera V, Capodaglio C, Sironi S. Multiorgan Involvement in SARS-CoV-2 Infection: The Role of the Radiologist from Head to Toe. Diagnostics 2022;12:1188. [DOI: 10.3390/diagnostics12051188] [Reference Citation Analysis]
115 Gomides APM, de Albuquerque CP, da Mota LMH, Devidé G, Dias LH, Duarte ALBP, Giovelli RA, Karnopp TE, de Lima HD, Marinho A, de Oliveira MS, Omura F, Ranzolin A, Resende G, Ribeiro FM, Ribeiro SLE, de Carvalho Sacilotto N, Dos Santos WG, Shinjo SK, de Sousa Studart SA, Teixeira FPS, Yazbek MA, Ferreira GA, Monticielo OA, Paiva E, Pileggi GCS, Dos Reis-Neto ET, de Medeiros Pinheiro M, Marques CDL; ReumaCoV Brasil Registry. Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry. Adv Rheumatol 2022;62:13. [PMID: 35505408 DOI: 10.1186/s42358-022-00244-5] [Reference Citation Analysis]
116 Ղազարյան Ա. SARS-COV-2 ՎԱՐԱԿ. ԱՌՈՂՋԱՊԱՀԱԿԱՆ ՆՈՐ ՄԱՐՏԱՀՐԱՎԵՐ (ԱԿՆԱՐԿ). MSEJ 2022. [DOI: 10.56936/18291775-2022.33-29] [Reference Citation Analysis]
117 Antala S, Diamond T, Kociolek LK, Shah AA, Chapin CA. Severe Hepatitis in Pediatric Coronavirus Disease 2019. J Pediatr Gastroenterol Nutr 2022;74:631-5. [PMID: 35149651 DOI: 10.1097/MPG.0000000000003404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
118 Leo M, Galante A, Pagnamenta A, Ruinelli L, Ponziani FR, Gasbarrini A, De Gottardi A. Hepatocellular liver injury in hospitalized patients affected by COVID-19: Presence of different risk factors at different time points. Dig Liver Dis 2022;54:565-71. [PMID: 35093272 DOI: 10.1016/j.dld.2021.12.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Samanta J, Singh S, Kumar S, Sharma M, Kochhar R. Gastrointestinal sequelae among COVID-19 patients after discharge and their predictors. Dig Liver Dis 2022;54:580-2. [PMID: 35216903 DOI: 10.1016/j.dld.2022.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Wang B, Zhang L, Wang Y, Dai T, Qin Z, Zhou F, Zhang L. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct Target Ther 2022;7:143. [PMID: 35487886 DOI: 10.1038/s41392-022-00986-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
121 Strambi S, Proietti A, Galatioto C, Coccolini F, Cremonini C, Musetti S, Basolo F, Chiarugi M, Tartaglia D. Intestinal Ischemia: Unusual but Fearsome Complication of COVID-19 Infection. Biomedicines 2022;10:1010. [DOI: 10.3390/biomedicines10051010] [Reference Citation Analysis]
122 Singh S, Samanta J, Suri V, Bhalla A, Puri GD, Sehgal R, Kochhar R. Presence of diarrhea associated with better outcomes in patients with COVID-19 - A prospective evaluation. Indian J Med Microbiol 2022:S0255-0857(22)00059-7. [PMID: 35483999 DOI: 10.1016/j.ijmmb.2022.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Bazhukhina IV, Klimova NV, Gaus AA, Petrova NN. The Role of Perfusion Computed Tomography as a Predictor of Pancreatic Necrosis in Acute Pancreatitis. jour 2022. [DOI: 10.52560/2713-0118-2022-3-11-23] [Reference Citation Analysis]
124 Ahmad R, Haque M. Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction. Vaccines (Basel) 2022;10:614. [PMID: 35455363 DOI: 10.3390/vaccines10040614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
125 Babajide OI, Ogbon EO, Adelodun A, Agbalajobi O, Ogunsesan Y. COVID‐19 and acute pancreatitis: A systematic review. JGH Open. [DOI: 10.1002/jgh3.12729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
126 Giron LB, Peluso MJ, Ding J, Kenny G, Zilberstein NF, Koshy J, Hong KY, Rasmussen H, Miller G, Bishehsari F, Balk RA, Moy JN, Hoh R, Lu S, Goldman AR, Tang H, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Kelly JD, Wasse H, Martin JN, Liu Q, Keshavarzian A, Landay A, Deeks SG, Henrich TJ, Abdel-mohsen M. Markers of Fungal Translocation Are Elevated During Post-Acute Sequelae of SARS-CoV-2 Infection and Induce NF-κB Triggered Inflammation.. [DOI: 10.1101/2022.04.12.488051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Acer PT, Kelly LM, Lover AA, Butler CS. Quantifying the relationship between SARS-CoV-2 wastewater concentrations and building-level COVID-19 prevalence at an isolation residence using a passive sampling approach. medRxiv 2022:2022. [PMID: 35441165 DOI: 10.1101/2022.04.07.22273534] [Reference Citation Analysis]
128 Kopańska M, Barnaś E, Błajda J, Kuduk B, Łagowska A, Banaś-ząbczyk A. Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body. IJMS 2022;23:4178. [DOI: 10.3390/ijms23084178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
129 Wu X, Jing H, Wang C, Wang Y, Zuo N, Jiang T, Novakovic VA, Shi J. Intestinal Damage in COVID-19: SARS-CoV-2 Infection and Intestinal Thrombosis. Front Microbiol 2022;13:860931. [PMID: 35391725 DOI: 10.3389/fmicb.2022.860931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 To A, Wong TAS, Lieberman MM, Thompson K, Ball AH, Pessaint L, Greenhouse J, Daham N, Cook A, Narvaez B, Flinchbaugh Z, Van Ry A, Yalley-Ogunro J, Andersen Elyard H, Lai CY, Donini O, Lehrer AT. A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant. ACS Infect Dis 2022;8:825-40. [PMID: 35263081 DOI: 10.1021/acsinfecdis.1c00600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
131 Ebrahim Nakhli R, Shanker A, Sarosiek I, Boschman J, Espino K, Sigaroodi S, Al Bayati I, Elhanafi S, Sadeghi A, Sarosiek J, Zuckerman MJ, Rezaie A, McCallum RW, Schmulson MJ, Bashashati A, Bashashati M. Gastrointestinal symptoms and the severity of COVID-19: Disorders of gut-brain interaction are an outcome. Neurogastroenterol Motil 2022;34:e14368. [PMID: 35383423 DOI: 10.1111/nmo.14368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
132 Yao L, Lu L, Ma W. Immunopathological changes, complications, sequelae and immunological memory in COVID-19 patients. Heliyon 2022;8:e09302. [PMID: 35497026 DOI: 10.1016/j.heliyon.2022.e09302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Guimarães Sousa S, Kleiton de Sousa A, Maria Carvalho Pereira C, Sofia Miranda Loiola Araújo A, de Aguiar Magalhães D, Vieira de Brito T, Barbosa ALDR. SARS-CoV-2 infection causes intestinal cell damage: Role of interferon’s imbalance. Cytokine 2022;152:155826. [DOI: 10.1016/j.cyto.2022.155826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
134 Gao Y, Liang W, Li Y, He J, Guan W. The Short- and Long-Term Clinical, Radiological and Functional Consequences of COVID-19. Archivos de Bronconeumología 2022. [DOI: 10.1016/j.arbres.2022.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
135 De R, Dutta S. Role of the Microbiome in the Pathogenesis of COVID-19. Front Cell Infect Microbiol 2022;12:736397. [DOI: 10.3389/fcimb.2022.736397] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
136 Al-Qahtani AA. Mutations in the genome of severe acute respiratory syndrome coronavirus 2: implications for COVID-19 severity and progression. J Int Med Res 2022;50:3000605221086433. [PMID: 35352580 DOI: 10.1177/03000605221086433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Горелов АВ, Захарова ИН, Макарова СГ, Ших ЕВ, Новик ГА, Усенко ДВ, Бережная ИВ. Консенсус экспертного совета. Дифференциальная диагностика диарейного синдрома в зависимости от его патогенеза в практике врача-педиатра, роль пробиотических лекарственных средств в его лечении. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-1-14-17] [Reference Citation Analysis]
138 Barnes E. Infection of liver hepatocytes with SARS-CoV-2. Nat Metab 2022. [PMID: 35347317 DOI: 10.1038/s42255-022-00554-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Han YJ, Lee KH, Lee J, Kim OY, Moon S, Kim S, Ryu S, Lee D, Kim JY, Kim T, Lee S, Bae S, Lee M, So J, Shin JI. Extrapulmonary clinical manifestations of COVID-19: an umbrella review of meta-analysis. Life Cycle 2022;2. [DOI: 10.54724/lc.2022.e6] [Reference Citation Analysis]
140 Lipták P, Banovcin P, Rosoľanka R, Prokopič M, Kocan I, Žiačiková I, Uhrik P, Grendar M, Hyrdel R. A machine learning approach for identification of gastrointestinal predictors for the risk of COVID-19 related hospitalization. PeerJ 2022;10:e13124. [PMID: 35341062 DOI: 10.7717/peerj.13124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
141 D’Ardes D, Boccatonda A, Cocco G, Fabiani S, Rossi I, Bucci M, Guagnano MT, Schiavone C, Cipollone F. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship. World J Gastroenterol 2022; 28(11): 1102-1112 [DOI: 10.3748/wjg.v28.i11.1102] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
142 Mcquaid C, Solorzano A, Dickerson I, Deane R. SARS-CoV-2 spike proteins uptake mediated by lipid raft ganglioside GM1 in human cerebrovascular cells.. [DOI: 10.1101/2022.03.20.485050] [Reference Citation Analysis]
143 Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science 2022;375:1122-7. [PMID: 35271343 DOI: 10.1126/science.abm8108] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 79.0] [Reference Citation Analysis]
144 Singla S, Goyal S. Antiviral activity of molnupiravir against COVID-19: a schematic review of evidences. Bull Natl Res Cent 2022;46. [DOI: 10.1186/s42269-022-00753-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
145 Wang Y, Li Y, Zhang Y, Liu Y, Liu Y. Are gastrointestinal symptoms associated with higher risk of Mortality in COVID-19 patients? A systematic review and meta-analysis. BMC Gastroenterol 2022;22:106. [PMID: 35255816 DOI: 10.1186/s12876-022-02132-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
146 Jung EM, Stroszczynski C, Wiesinger I. Ultraschall bei COVID-19-Patienten. Radiologie up2date 2022;22:53-67. [DOI: 10.1055/a-1561-9427] [Reference Citation Analysis]
147 Tews H, Kandulski A, Schmid S, Peschel G, Gülow K, Schlosser S, Schirner S, Stroszczynski C, Müller M, Jung E. Contrast enhanced ultrasonography (CEUS) a novel tool to detect intestinal epithelial barrier dysfunction in severe COVID-19 disease. CH 2022. [DOI: 10.3233/ch-221407] [Reference Citation Analysis]
148 Yang Z, Leng L, Li M, Chu J. A computer-aid multi-task light-weight network for macroscopic feces diagnosis. Multimed Tools Appl. [DOI: 10.1007/s11042-022-12565-0] [Reference Citation Analysis]
149 Liu A, Raja xavier J, Singh Y, Brucker SY, Salker MS. Molecular and Physiological Aspects of SARS-CoV-2 Infection in Women and Pregnancy. Front Glob Womens Health 2022;3:756362. [DOI: 10.3389/fgwh.2022.756362] [Reference Citation Analysis]
150 Ning Q, Wu D, Wang X, Xi D, Chen T, Chen G, Wang H, Lu H, Wang M, Zhu L, Hu J, Liu T, Ma K, Han M, Luo X. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther 2022;7:57. [PMID: 35197452 DOI: 10.1038/s41392-022-00907-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
151 Neuberger M, Jungbluth A, Irlbeck M, Streitparth F, Burian M, Kirchner T, Werner J, Rudelius M, Knösel T. Duodenal tropism of SARS-CoV-2 and clinical findings in critically ill COVID-19 patients. Infection 2022. [PMID: 35182354 DOI: 10.1007/s15010-022-01769-z] [Reference Citation Analysis]
152 Schult D, Reitmeier S, Koyumdzhieva P, Lahmer T, Middelhof M, Erber J, Schneider J, Kager J, Frolova M, Horstmann J, Fricke L, Steiger K, Jesinghaus M, Janssen KP, Protzer U, Neuhaus K, Schmid RM, Haller D, Quante M. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. Gut Microbes 2022;14:2031840. [PMID: 35174781 DOI: 10.1080/19490976.2022.2031840] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
153 Sönmez RE, Şimşek Fİ, Alimoglu O. Presence of SARS-CoV-2 in peritoneal fluid and its significance in clinical course: A review analysis. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi 2022. [DOI: 10.20492/aeahtd.827326] [Reference Citation Analysis]
154 Hasel K, Salim A, Verma S, D'adamo C, Arrup D, Vinayek R, Dutta SK. Prevalence of Gastrointestinal Symptoms, Hepatic Dysfunction, and Outcomes in Hospitalized Patients With COVID-19 Infection: An Early Experience. Cureus 2022. [DOI: 10.7759/cureus.22152] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
155 Xiang Q, Cheng L, Zhang R, Liu Y, Wu Z, Zhang X. Tea Polyphenols Prevent and Intervene in COVID-19 through Intestinal Microbiota. Foods 2022;11:506. [DOI: 10.3390/foods11040506] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
156 Bosa L, Di Chiara C, Gaio P, Cosma C, Padoan A, Cozzani S, Perilongo G, Plebani M, Giaquinto C, Donà D, Cananzi M. Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease. Front Pediatr 2022;10:815857. [DOI: 10.3389/fped.2022.815857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Li W, Yang S, Xu P, Zhang D, Tong Y, Chen L, Jia B, Li A, Lian C, Ru D, Zhang B, Liu M, Chen C, Fu W, Yuan S, Gu C, Wang L, Li W, Liang Y, Yang Z, Ren X, Wang S, Zhang X, Song Y, Xie Y, Lu H, Xu J, Wang H, Yu W. SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network. EBioMedicine 2022;76:103861. [PMID: 35124429 DOI: 10.1016/j.ebiom.2022.103861] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
158 Abbas HD, Kadhim SJ. A Physiological Study to Evaluate Liver Function in Male and Female Patients Infected with COVID-19 Virus in Najaf City. Open Access Maced J Med Sci 2022;10:1-4. [DOI: 10.3889/oamjms.2022.9427] [Reference Citation Analysis]
159 Desquilles L, Cano L, Ghukasyan G, Mouchet N, Landreau C, Corlu A, Clément B, Turlin B, Désert R, Musso O. Well-differentiated liver cancers reveal the potential link between ACE2 dysfunction and metabolic breakdown. Sci Rep 2022;12:1859. [PMID: 35115564 DOI: 10.1038/s41598-021-03710-0] [Reference Citation Analysis]
160 Chen J, He Z, Wang F. Evaluation of ferritin level in COVID-19 patients and its inflammatory response. Appl Nanosci. [DOI: 10.1007/s13204-021-02115-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
161 Khan MUF, Ali BR, Mohammed HQ, Al-Shammari HMT, Jalil AT, Hindi NKK, Suksatan W, Saeed BQ, Obaid RF, Saleh MM, Kadhim MM. Serum level estimation of some biomarkers in diabetic and non-diabetic COVID-19 infected patients. Appl Nanosci 2022;:1-8. [PMID: 35136705 DOI: 10.1007/s13204-021-02167-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
162 Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol 2022;23:194-202. [PMID: 35105985 DOI: 10.1038/s41590-021-01104-y] [Cited by in Crossref: 90] [Cited by in F6Publishing: 102] [Article Influence: 90.0] [Reference Citation Analysis]
163 Di Pilato V, Morecchiato F, Rizzato C, Quaranta G, Fais R, Gandolfo C, Antonelli A, Cusi MG, Pistello M, Rossolini GM, Sanguinetti M, Lupetti A, Masucci L. Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation. Microorganisms 2022;10:284. [DOI: 10.3390/microorganisms10020284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Sun Z, Song ZG, Liu C, Tan S, Lin S, Zhu J, Dai FH, Gao J, She JL, Mei Z, Lou T, Zheng JJ, Liu Y, He J, Zheng Y, Ding C, Qian F, Zheng Y, Chen YM. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. BMC Med 2022;20:24. [PMID: 35045853 DOI: 10.1186/s12916-021-02212-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 27.0] [Reference Citation Analysis]
165 Ni Y, Zeng H, Song X, Zheng J, Wu H, Liu C, Zhang Y. Potential metal-related strategies for prevention and treatment of COVID-19. Rare Met . [DOI: 10.1007/s12598-021-01894-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Hakami NY, Al-sulami AJ, Alhazmi WA, Qadah TH, Bawazir WM, Hamadi AY, Owaidah AY, Alhefzi RA, Hamdi FY, Maqnas A, Alghassab GF, Badawi MA, Hindawi SI, Lo Giudice R. Impact of COVID-19 on Blood Donation and Supply: A Multicenter Cross-Sectional Study from Saudi Arabia. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/1474426] [Reference Citation Analysis]
167 Furuyama W, Shifflett K, Pinski AN, Griffin AJ, Feldmann F, Okumura A, Gourdine T, Jankeel A, Lovaglio J, Hanley PW, Thomas T, Clancy CS, Messaoudi I, O'Donnell KL, Marzi A. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine. mBio 2022;:e0337921. [PMID: 35012339 DOI: 10.1128/mbio.03379-21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
168 Fathi M, Markazi Moghaddam N, Kheyrati L. Development and validation of models for two‐week mortality of inpatients with COVID ‐19 infection: A large prospective cohort study. Statistical Analysis. [DOI: 10.1002/sam.11572] [Reference Citation Analysis]
169 Salman R, Sher AC, Sammer MBK, Rodriguez JR, Shah SR, Seghers VJ. Ileocolic intussusception in pediatric SARS-CoV-2 patients: experience at a tertiary pediatric center. Pediatr Surg Int 2022. [PMID: 34999941 DOI: 10.1007/s00383-022-05061-x] [Reference Citation Analysis]
170 Pazgan-Simon M, Serafińska S, Kukla M, Kucharska M, Zuwała-Jagiełło J, Buczyńska I, Zielińska K, Simon K. Liver Injury in Patients with COVID-19 without Underlying Liver Disease. J Clin Med 2022;11:308. [PMID: 35054003 DOI: 10.3390/jcm11020308] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
171 Shadi MS, Farahat M. Self-perceived dysphagia in non-invasively ventilated COVID-19 patients. Eur Arch Otorhinolaryngol 2022;279:5929-37. [PMID: 35947148 DOI: 10.1007/s00405-022-07557-7] [Reference Citation Analysis]
172 Marasco G, Cremon C, Barbaro MR, Salvi D, Cacciari G, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yağcı MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi İ, Koc ES, Sirin G, Calıskan AR, Bengi G, Alıs EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjolund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Stefano M, Maggio M, Philippou E, Lee YY, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G; GI-COVID19 Study Group. Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study. Am J Gastroenterol 2022;117:147-57. [PMID: 34751672 DOI: 10.14309/ajg.0000000000001541] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
173 Ostroumova O, Polyakova O, Kochetkov A. The use of acetylsalicylic acid for prevention of cardiovascular complications in patients undergoing COVID-19. A review of current recommendations. Kardiol serdechno-sosud khir 2022;15:656. [DOI: 10.17116/kardio202215061656] [Reference Citation Analysis]
174 Elsaadi A, Buhavac M, Bankhead BK. The Impact of COVID-19 on Surgical Disease. Frontiers of COVID-19 2022. [DOI: 10.1007/978-3-031-08045-6_19] [Reference Citation Analysis]
175 E. S. Lapteva, A. L. Ariev, G. T. Arieva, M. R. Tsutsunawa, D. C. Diachkova-Gerceva. On the Role of Geriatric Services in the Diagnosis and Monitoring of Outcomes of Post-Covid Syndrome (Review). Adv Gerontol 2022;12. [ DOI: 10.1134/S2079057022040105] [Reference Citation Analysis]
176 Shoupe D. Reproductive Effects of COVID-19: A Journey through COVID-19 Pathogenesis. Handbook of Gynecology 2022. [DOI: 10.1007/978-3-319-17002-2_97-1] [Reference Citation Analysis]
177 Aroniadis OC, Wang X, Gong T, Forbes N, Yang JY, Canakis A, Elmunzer BJ, Yadav D; North American Alliance for the Study of Digestive Manifestations of Covid-19. Factors Associated with the Development of Gastrointestinal Symptoms in Patients Hospitalized with Covid-19. Dig Dis Sci 2022;67:3860-71. [PMID: 34751837 DOI: 10.1007/s10620-021-07286-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
178 Feofanova TB, Zaletova TS, Zainudinov ZM. Assessment of the metabolic status of patients with comorbid pathology after COVID-19. Juvenis scientia 2022;8:31-38. [DOI: 10.32415/jscientia_2022_8_3_31-38] [Reference Citation Analysis]
179 Bassetti M, Vena A, Giacobbe DR, Briano F, Portunato F. Gastrointestinal Manifestations of COVID-19. COVID-19 Critical and Intensive Care Medicine Essentials 2022. [DOI: 10.1007/978-3-030-94992-1_21] [Reference Citation Analysis]
180 Luan J, Ren Y, Gao S, Zhang L. High level of defensin alpha 5 in intestine may explain the low incidence of diarrhoea in COVID-19 patients. Eur J Gastroenterol Hepatol 2022;34:e3-4. [PMID: 32976188 DOI: 10.1097/MEG.0000000000001941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
181 Narasimhan B, Lorente-ros M, Narasimhan H, Aronow WS. Acute Vascular Injury in COVID-19. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_8] [Reference Citation Analysis]
182 Zhao W, Zhang X, Zhu F, Jiang X. Dynamic Changes of Liver Function Indexes in Patients with Different Clinical Types of COVID-19. IJGM 2022;Volume 15:877-84. [DOI: 10.2147/ijgm.s347291] [Reference Citation Analysis]
183 Chaugale SB, Singhal V, Kapoor D, Singh A. Gastrointestinal complications (gangrene or perforation) after corona virus disease 2019 - A series of ten patients. Indian J Gastroenterol 2022;41:307-12. [PMID: 35471720 DOI: 10.1007/s12664-021-01218-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
184 Prathipati KK, Mishra M, Rathod B, Tripathy JP, B H S, Bidkar V, Dabhekar S, Shete V, G D. Symptomatology and Relationship Between Symptoms and Duration Among COVID-19 Patients in a COVID-19 Care Hospital in Central India. Cureus 2022;14:e21541. [PMID: 35223314 DOI: 10.7759/cureus.21541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
185 Marsán-Suárez V, Casado-Hernández I, Hernández-Ramos E, Díaz-Domínguez G, Triana-Marrero Y, Duarte-Pérez Y, Miranda-Navarro J, Bringas-Pérez R, Simón-Pita AM, Hernández-Rego YLM, Miguel-Morales M, Patria-Sánchez M, Zamora-González Y, Romero-Díaz Y, Aquino-Rojas S, González-Díaz I, Merlín-Linares JC, Leyva-Rodríguez A, Rodríguez-Pérez M, Benito-Caballero O, Navarro-Mariño JA, Elejalde-Larrinaga AR, Elejalde-Tamayo C, Tam-Rey LM, Ruiz-Villegas L, de la Guardia-Peña OM, Jerez-Barcel Y, Chang-Monteagudo A, Lam-Díaz RM, Macías-Abraham CM. Biomarkers of sequela in adult patients convalescing from COVID-19. Adv Biomark Sci Technol 2022;4:36-53. [PMID: 36404876 DOI: 10.1016/j.abst.2022.10.001] [Reference Citation Analysis]
186 Timerbulatov M, Aitova L, Grishina E, Sakaev E, Shchekin V, Shchekin S, Nizamutdinov T. Severe pseudomembranous colitis in patients with previous coronavirus infection. Khir Z im N I Pirogova 2022. [DOI: 10.17116/hirurgia202208153] [Reference Citation Analysis]
187 Deng J, Bao Y, Tian S, Yuan K, Zheng Y, Gao X, Chen X, Yang Y, Meng S, Cao L, Shi L, Yan W, Liu X, Shi J, Lu L. Efficacy and safety of traditional chinese medicine combined with western medicine for the treatment of COVID-19: A systematic review and meta-analysis. Heart Mind 2022;6:105. [DOI: 10.4103/hm.hm_10_22] [Reference Citation Analysis]
188 Diallo S, Fall AB, Bassène ML, Gueye MN, Fall MP, Thioubou MA, Yauck A, Fall AAA, Faye A. Clinical Characteristics of COVID-19 Patients with Digestive Symptoms: A Retrospective Study from Dakar, Senegal. OJGas 2022;12:89-97. [DOI: 10.4236/ojgas.2022.124009] [Reference Citation Analysis]
189 Haithem H, Sadik H, Hayder A. Abdominal pain in children with COVID-19. Khir Z im N I Pirogova 2022. [DOI: 10.17116/hirurgia202210158] [Reference Citation Analysis]
190 Gupta D, Awadhiya O, Saigal S, Kumar A. Structure, genomic analysis, and pathogenesis of SARS-CoV-2. Advanced Biosensors for Virus Detection 2022. [DOI: 10.1016/b978-0-12-824494-4.00003-5] [Reference Citation Analysis]
191 Shah SC, Canakis A, Halvorson AE, Dorn C, Wilson O, Denton J, Hauger R, Hunt C, Suzuki A, Matheny ME, Siew E, Hung A, Greevy RA Jr, Roumie CL. Associations Between Gastrointestinal Symptoms and COVID-19 Severity Outcomes Based on a Propensity Score-Weighted Analysis of a Nationwide Cohort. Gastro Hep Adv 2022;1:977-84. [PMID: 35966642 DOI: 10.1016/j.gastha.2022.06.015] [Reference Citation Analysis]
192 Sosnowska B, Bielecka-dabrowa A, Banach M. Prognosis in COVID-19 Patients: Statistics, Risk Factors. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_5] [Reference Citation Analysis]
193 Shimizu K, Hirata H, Kabata D, Tokuhira N, Koide M, Ueda A, Tachino J, Shintani A, Uchiyama A, Fujino Y, Ogura H. Ivermectin administration is associated with lower gastrointestinal complications and greater ventilator-free days in ventilated patients with COVID-19: A propensity score analysis. J Infect Chemother 2021:S1341-321X(21)00360-3. [PMID: 35016823 DOI: 10.1016/j.jiac.2021.12.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
194 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
195 Ashraf H, Ghafouri P, Kazemian S, Soleimani A, Sadat Naseri A, Karbalai S, Kazemi Saeid A. Hydroxychloroquine alone or in combination with azithromycin and corrected QT prolongation in COVID-19 patients: A systematic review. World J Meta-Anal 2021; 9(6): 557-567 [DOI: 10.13105/wjma.v9.i6.557] [Reference Citation Analysis]
196 Bautista-Becerril B, Pérez-Dimas G, Sommerhalder-Nava PC, Hanono A, Martínez-Cisneros JA, Zarate-Maldonado B, Muñoz-Soria E, Aquino-Gálvez A, Castillejos-López M, Juárez-Cisneros A, Lopez-Gonzalez JS, Camarena A. miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19. Viruses 2021;14:41. [PMID: 35062245 DOI: 10.3390/v14010041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
197 Im H, Ser J, Sim U, Cho H. Promising Expectations for Pneumococcal Vaccination during COVID-19. Vaccines (Basel) 2021;9:1507. [PMID: 34960253 DOI: 10.3390/vaccines9121507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
198 Mukherjee R, Chaudhuri D, Mitra AK, Guchhait P, Bhowmik S, Das S, Chaudhuri BN. Demographic Features of COVID-19 in Two Waves in A Single Center. Journal of Microbiology and Infectious Diseases 2021. [DOI: 10.5799/jmid.1036705] [Reference Citation Analysis]
199 Khan MU, Mushtaq K, Alsoub DH, Iqbal P, Ata F, Chaudhry HS, Iqbal F, Balaraju G, Maslamani MAA, Varughese B, Singh R, Ejji KA, Kaabi SA, Kamel YM, Butt AA. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar. World J Gastroenterol 2021; 27(46): 7995-8009 [DOI: 10.3748/wjg.v27.i46.7995] [Reference Citation Analysis]
200 Khan MU, Mushtaq K, Alsoub DH, Iqbal P, Ata F, Chaudhry HS, Iqbal F, Balaraju G, Maslamani MAA, Varughese B, Singh R, Ejji KA, Kaabi SA, Kamel YM, Butt AA. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar. WJG 2021;27:7995-8009. [DOI: 10.3748/wjg.v27.i46.7995] [Reference Citation Analysis]
201 D. Lakhani J, Kapadia S, Choradiya R, Preet Gill R, J. Lakhani S. COVID-19 and Multiorgan Dysfunction Syndrome. Fighting the COVID-19 Pandemic 2021. [DOI: 10.5772/intechopen.99676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
202 Karna ST, Singh P, Revadi G, Khurana A, Shivhare A, Saigal S, Rathiswamy MK, Sharma JP, Waindeskar V. Frequency and Impact of Preadmission Digestive Symptoms on Outcome in Severe COVID-19: A Prospective Observational Cohort Study. Indian J Crit Care Med 2021;25:1247-57. [PMID: 34866821 DOI: 10.5005/jp-journals-10071-24020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 Stolfi I, Conti MG, Marciano A, Dito L, Natale F, Bartolucci M, Cellitti R, Regoli D, Ticchiarelli A, Pangallo I, Pagano F, Ajassa C, Brunelli R, Terrin G. Liver Involvement in SARS-CoV-2 Vertically Infected Newborn: A Case Report. Front Pediatr 2021;9:701722. [PMID: 34858898 DOI: 10.3389/fped.2021.701722] [Reference Citation Analysis]
204 Khan N, Lamb L, Moores R. Clinical features and acute management of COVID-19 in adults. COVID-19 2021. [DOI: 10.1183/2312508x.10025520] [Reference Citation Analysis]
205 Zhang MM, Chen LN, Qian JM. Gastrointestinal manifestations and possible mechanisms of COVID-19 in different periods. J Dig Dis 2021;22:683-94. [PMID: 34738727 DOI: 10.1111/1751-2980.13065] [Reference Citation Analysis]
206 Anirvan P, Narain S, Hajizadeh N, Aloor FZ, Singh SP, Satapathy SK. Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots. Eur J Gastroenterol Hepatol 2021;33:e42-9. [PMID: 33405427 DOI: 10.1097/MEG.0000000000002034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
207 Chaubal G, Hatimi H, Nanavati A, Deshpande A, Andankar P, Biradar V, Gupte P, Hanchnale P, Bhalerao S, Tambe S. Pediatric living donor intestine transplant following an atypical complication of COVID-19: A unique case report from India. Am J Transplant 2021;21:4079-83. [PMID: 34390165 DOI: 10.1111/ajt.16798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
208 Goel H, Harmouch F, Garg K, Saraiya P, Daly T, Kumar A, Hippen JT. The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities. Eur J Gastroenterol Hepatol 2021;33:e274-81. [PMID: 33369962 DOI: 10.1097/MEG.0000000000002021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
209 Bamias G, Kokkotis G, Christidou A, Christodoulou DK, Delis V, Diamantopoulou G, Fessatou S, Gatopoulou A, Giouleme O, Kafritsa P, Kalantzis C, Kapsoritakis A, Karatzas P, Karmiris K, Katsanos K, Kevrekidou P, Kosmidis C, Mantaka A, Mathou N, Michalopoulos G, Michopoulos S, Papaconstantinou I, Papatheodoridis G, Polymeros D, Potamianos S, Poulopoulos G, Protopapas A, Sklavaina M, Soufleris K, Theocharis G, Theodoropoulou A, Triantafillidis JK, Triantafyllou K, Tsiolakidou G, Tsironi E, Tzouvala M, Viazis N, Xourgias V, Zacharopoulou E, Zampeli E, Mantzaris GJ. The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD. Eur J Gastroenterol Hepatol 2021;33:e810-7. [PMID: 34402469 DOI: 10.1097/MEG.0000000000002267] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
210 Sirinawasatien A, Chantarojanasiri T, Ekpanyapong S, Tivatunsakul N, Luvira V. Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review. JGH Open 2021;5:1257-65. [PMID: 34816011 DOI: 10.1002/jgh3.12671] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
211 Pellegrini JR Jr, Sabbula B, Russe-Russe JR, Munshi RF, Meshoyrer D, Sajid N, Gutierrez A, Munnangi S, Szydziak E, Akella J. A Retrospective Analysis of COVID-19-infected Patients with Acute Hepatitis who Develop Acute Liver Failure in a Safety Net Hospital. BMJ Open Gastroenterol 2021;8:e000738. [PMID: 34810216 DOI: 10.1136/bmjgast-2021-000738] [Reference Citation Analysis]
212 Liviero F, Campisi M, Mason P, Pavanello S. Transient Receptor Potential Vanilloid Subtype 1: Potential Role in Infection, Susceptibility, Symptoms and Treatment of COVID-19. Front Med (Lausanne) 2021;8:753819. [PMID: 34805220 DOI: 10.3389/fmed.2021.753819] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
213 Brady M, McQuaid C, Solorzano A, Johnson A, Combs A, Venkatraman C, Rahman A, Leyva H, Kwok WE, Wood RW, Deane R. Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2. Commun Biol 2021;4:1318. [PMID: 34811493 DOI: 10.1038/s42003-021-02856-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
214 Goma TV, Kozlova NM, Bykov YN. Mallory- Weiss syndrome associated with new coronavirus infection COVID-19. jour 2021. [DOI: 10.31146/1682-8658-ecg-192-8-175-180] [Reference Citation Analysis]
215 Patel RK, Chandel K, Mittal S, Tripathy T. Abdominal Computed Tomography Findings among COVID-19 Patients with Index Gastrointestinal Manifestations: A Preliminary Single-center Experience. Euroasian J Hepatogastroenterol 2021;11:76-80. [PMID: 34786360 DOI: 10.5005/jp-journals-10018-1346] [Reference Citation Analysis]
216 Aslan AT, Şimşek H. Clinical Features and Pathophysiological Mechanisms of COVID-19-associated Gastrointestinal Manifestations. Euroasian J Hepatogastroenterol 2021;11:81-6. [PMID: 34786361 DOI: 10.5005/jp-journals-10018-1347] [Reference Citation Analysis]
217 Sweed D, Abdelsameea E, Khalifa EA, Abdallah H, Moaz H, Moaz I, Abdelsattar S, Abdel-Rahman N, Mosbeh A, Elmahdy HA, Sweed E. SARS-CoV-2-associated gastrointestinal and liver diseases: what is known and what is needed to explore. Egypt Liver J 2021;11:64. [PMID: 34777871 DOI: 10.1186/s43066-021-00123-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
218 Faghih Dinevari M, Rasoolimanesh M, Tarverdizadeh M, Riazi A, Abbasian S, Zeinolabedini A, Hassannezhad S. Acute pancreatitis in a young woman with COVID-19 infection: A case-report. Caspian J Intern Med 2021;12:S474-8. [PMID: 34760109 DOI: 10.22088/cjim.12.0.474] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 He J, Song C, Liu E, Liu X, Wu H, Lin H, Liu Y, Li Q, Xu Z, Ren X, Zhang C, Zhang W, Duan W, Tian Y, Li P, Hu M, Yang S, Xu Y. Establishment of Routine Clinical Indicators-Based Nomograms for Predicting the Mortality in Patients With COVID-19. Front Med (Lausanne) 2021;8:706380. [PMID: 34733858 DOI: 10.3389/fmed.2021.706380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
220 Li S, Yang S, Zhou Y, Disoma C, Dong Z, Du A, Zhang Y, Chen Y, Huang W, Chen J, Song D, Chen Z, Liu P, Li S, Zheng R, Liu S, Razzaq A, Chen X, Tao S, Yu C, Feng T, Liao W, Peng Y, Jiang T, Huang J, Wu W, Hu L, Wang L, Li S, Xia Z. Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota. Front Microbiol 2021;12:712081. [PMID: 34707577 DOI: 10.3389/fmicb.2021.712081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
221 Gaspar R, Castelo Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021; 13(10): 1367-1377 [PMID: 34786172 DOI: 10.4254/wjh.v13.i10.1367] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
222 Shi Q, Wang Z, Liu J, Wang X, Zhou Q, Li Q, Yu Y, Luo Z, Liu E, Chen Y; COVID-19 evidence and recommendations working group. Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2021;41:101155. [PMID: 34693233 DOI: 10.1016/j.eclinm.2021.101155] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
223 Niavarani A, Poustchi H, Shayanrad A, Sharafkhah M, Mohammadi Z, Mansour-Ghanaei F, Joukar F, Roshandel G, Hormati A, Ghadimi R, Sadeghniiat-Haghighi K, Abdollahi A, Mardani M, Bahadorimonfared A, Ghanbari S, Delavari A, Vosoogh-Moghaddam A, Zamani M, Roozafzai F, Alvand S, Darvishian M, Malekzadeh R. Dynamics of the COVID-19 Clinical Findings and the Serologic Response. Front Microbiol 2021;12:743048. [PMID: 34690989 DOI: 10.3389/fmicb.2021.743048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
224 Haleema N, Mahnoor A, Umar S, Zahra Zahid P, Rafia T, Noor- U, Farrah M, Rida F, Rizwan U. SARS-CoV-2 infection-associated detrimental effects on the various human organs. Int J Clin Virol 2021;5:072-081. [DOI: 10.29328/journal.ijcv.1001038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
225 Longo de Freitas C, Okochi Alves da silva PY, Pinho Franco MDC, De Almeida DC. COVID-19: Impact in endothelial function and therapy with Mesenchymal Stromal Cells. Magna Sci UCEVA 2021;1:2-7. [DOI: 10.54502/msuceva.v1n1a2] [Reference Citation Analysis]
226 Ismail K, Bensasi H, Taha A, Nazir A, Abdelkhalek M, Mohamed W, Lodhe D, Buschbeck S, Bauer M, Sakr Y. Characteristics and outcome of critically ill patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to a tertiary care center in the United Arab Emirates during the first wave of the SARS-CoV-2 pandemic. A retrospective analysis. PLoS One 2021;16:e0251687. [PMID: 34679109 DOI: 10.1371/journal.pone.0251687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
227 Akhmedzhanova LT, Ostroumova TM, Solokha OA. Management of patients with pain syndromes associated with COVID-19. RJTAO 2021;13:96-101. [DOI: 10.14412/2074-2711-2021-5-96-101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
228 Wang X, Lei J, Li Z, Yan L. Potential Effects of Coronaviruses on the Liver: An Update. Front Med (Lausanne) 2021;8:651658. [PMID: 34646834 DOI: 10.3389/fmed.2021.651658] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
229 Hawlader MDH, Rashid MU, Khan MAS, Ara T, Nabi MH, Haque MMA, Matin KF, Hossain MA, Rahman MA, Hossian M, Saha S, Manna RM, Arafat MY, Barsha SY, Maliha R, Khan JZ, Kha S, Hasan SMR, Hasan M, Siddiquea SR, Khan J, Islam AMK, Rashid R, Nur N, Khalid O, Bari F, Rahman ML. Quality of life of COVID-19 recovered patients in Bangladesh. PLoS One 2021;16:e0257421. [PMID: 34644332 DOI: 10.1371/journal.pone.0257421] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
230 Balderramo D, Mattos AZ, Mulqui V, Chiesa T, Plácido-Damián Z, Abarca J, Bolomo A, Carlino Y, Bombassaro IZ, Wiltgen D, Castillo LT, Díaz K, Acuña J, Manero E, Prieto J, Carrera E, Díaz-Ferrer J, Debes JD. Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID-19: A Multicenter Study from South America. Can J Gastroenterol Hepatol 2021;2021:1622533. [PMID: 34621710 DOI: 10.1155/2021/1622533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
231 Schult D, Reitmeier S, Koyumdzhieva P, Lahmer T, Middelhoff M, Erber J, Schneider J, Kager J, Frolova M, Horstmann J, Fricke L, Steiger K, Jesinghaus M, Janssen K, Protzer U, Neuhaus K, Schmid RM, Haller D, Quante M. Gut Bacterial Dysbiosis and Instability is Associated with the Onset of Complications and Mortality in COVID-19.. [DOI: 10.1101/2021.10.08.463613] [Reference Citation Analysis]
232 Timofeeva AA, Shulpekova YO, Nechaev VM, Skhirtladze MR. <i>Сlostridium difficile</i> Infection in a COVID-19 Patient. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2021;31:68-73. [DOI: 10.22416/1382-4376-2021-31-3-68-73] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
233 Sodeifian F, Seyedalhosseini ZS, Kian N, Eftekhari M, Najari S, Mirsaeidi M, Farsi Y, Nasiri MJ. Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review. Front Med (Lausanne) 2021;8:731436. [PMID: 34616757 DOI: 10.3389/fmed.2021.731436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
234 Ribeiro IB, de Moura DTH, de Moura EGH. Gastrointestinal symptoms in patients with COVID-19: Is there a relationship with mortality and new variations of SARS-CoV-2? World J Gastroenterol 2021;27:6345-7. [PMID: 34712037 DOI: 10.3748/wjg.v27.i37.6345] [Reference Citation Analysis]
235 Silva FAFD, de Brito BB, Santos MLC, Marques HS, da Silva Júnior RT, de Carvalho LS, de Sousa Cruz S, Rocha GR, Correa Santos GL, de Souza KC, Maciel RGA, Lopes DS, Silva NOE, Oliveira MV, de Melo FF. Transmission of severe acute respiratory syndrome coronavirus 2 via fecal-oral: Current knowledge. World J Clin Cases 2021; 9(28): 8280-8294 [PMID: 34754839 DOI: 10.12998/wjcc.v9.i28.8280] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
236 Li Y, Zhao W, Liu J, Chen Z, Lv Q, Zhang Z. Immunotherapy Summary for Cytokine Storm in COVID-19. Front Pharmacol 2021;12:731847. [PMID: 34603047 DOI: 10.3389/fphar.2021.731847] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
237 Patel S, Parikh C, Verma D, Sundararajan R, Agrawal U, Bheemisetty N, Akku R, Sánchez-Velazco D, Waleed MS. Bowel ischemia in COVID-19: A systematic review. Int J Clin Pract 2021;:e14930. [PMID: 34605117 DOI: 10.1111/ijcp.14930] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
238 Pegoraro F, Trapani S, Indolfi G. Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children. Clin Res Hepatol Gastroenterol 2021;46:101818. [PMID: 34607068 DOI: 10.1016/j.clinre.2021.101818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
239 Kopiczko N, Kwiatek-Średzińska K, Uścinowicz M, Kowalczuk-Krystoń M, Lebensztejn DM. SARS-CoV-2 Infection as a Cause of Acute Pancreatitis in a Child-A Case Report. Pediatr Rep 2021;13:552-7. [PMID: 34698241 DOI: 10.3390/pediatric13040065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
240 Piotrowicz K, Gąsowski J, Michel JP, Veronese N. Post-COVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res 2021;33:2887-98. [PMID: 34328636 DOI: 10.1007/s40520-021-01942-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 21.5] [Reference Citation Analysis]
241 Quintero Marzola ID, Fontalvo Mendoza MF, Cárdenas Gómez JC, Sibaja Pérez AE, Quintana Pájaro L, Ramos Villegas Y, Manzur Jattin FG, Yepes Barreto IDJ. Hígado y SARS-CoV-2: aspectos claves de la literatura. Rev colomb Gastroenterol 2021;36:485-493. [DOI: 10.22516/25007440.619] [Reference Citation Analysis]
242 Chew M, Tang Z, Radcliffe C, Caruana D, Doilicho N, Ciarleglio MM, Deng Y, Garcia-Tsao G. Significant Liver Injury During Hospitalization for COVID-19 Is Not Associated With Liver Insufficiency or Death. Clin Gastroenterol Hepatol 2021;19:2182-2191.e7. [PMID: 34004326 DOI: 10.1016/j.cgh.2021.05.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
243 Gozzi-Silva SC, Teixeira FME, Duarte AJDS, Sato MN, Oliveira LM. Immunomodulatory Role of Nutrients: How Can Pulmonary Dysfunctions Improve? Front Nutr 2021;8:674258. [PMID: 34557509 DOI: 10.3389/fnut.2021.674258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
244 To A, Wong TAS, Lieberman MM, Thompson K, Pessaint L, Greenhouse J, Daham N, Cook A, Narvaez B, Flinchbaugh Z, Ry AV, Yalley-ogunro J, Elyard HA, Lai C, Donini O, Lehrer AT. Protein Vaccine Induces a Durable, More Broadly Neutralizing Antibody Response in Macaques than Natural Infection with SARS-CoV-2 P.1.. [DOI: 10.1101/2021.09.24.461759] [Reference Citation Analysis]
245 Knyazev E, Nersisyan S, Tonevitsky A. Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers. Front Immunol 2021;12:636966. [PMID: 34557180 DOI: 10.3389/fimmu.2021.636966] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
246 Krysko O, Kondakova E, Vershinina O, Galova E, Blagonravova A, Gorshkova E, Bachert C, Ivanchenko M, Krysko DV, Vedunova M. Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study. Front Immunol 2021;12:715072. [PMID: 34539644 DOI: 10.3389/fimmu.2021.715072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
247 Paštrovic F, Lucijanic M, Atic A, Stojic J, Barisic Jaman M, Tjesic Drinkovic I, Zelenika M, Milosevic M, Medic B, Loncar J, Mijic M, Filipec Kanizaj T, Kralj D, Lerotic I, Virovic Jukic L, Ljubicic N, Luetic K, Grgic D, Majerovic M, Ostojic R, Krznaric Z, Luksic I, Piskac Zivkovic N, Keres T, Grabovac V, Persec J, Barsic B, Grgurevic I. Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients. J Clin Med 2021;10:4222. [PMID: 34575333 DOI: 10.3390/jcm10184222] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
248 Ikemura M, Tomishima K, Ushio M, Takahashi S, Yamagata W, Takasaki Y, Suzuki A, Ito K, Ochiai K, Ishii S, Saito H, Fujisawa T, Nagahara A, Isayama H. Impact of the Coronavirus Disease-2019 Pandemic on Pancreaticobiliary Disease Detection and Treatment. J Clin Med 2021;10:4177. [PMID: 34575288 DOI: 10.3390/jcm10184177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
249 Neri P, Pichi F. SARS-CoV-2 and the Eye: The Pandora's Box of Ocular Immunology. J Ocul Pharmacol Ther 2021;37:502-9. [PMID: 34515538 DOI: 10.1089/jop.2021.0058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
250 Bo W, Xi Y, Tian Z. The role of exercise in rehabilitation of discharged COVID-19 patients. Sports Med Health Sci 2021. [PMID: 34541561 DOI: 10.1016/j.smhs.2021.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
251 Hakim A, Hasan MM, Hasan M, Lokman SM, Azim KF, Raihan T, Chowdhury PA, Azad AK. Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges. Front Microbiol 2021;12:637554. [PMID: 34512561 DOI: 10.3389/fmicb.2021.637554] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
252 Tam SY, Tam VCW, Law HKW, Khaw ML, Lee SWY. Rationale for Mass Masking in Controlling the COVID-19 Pandemic. Front Public Health 2021;9:665708. [PMID: 34504826 DOI: 10.3389/fpubh.2021.665708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
253 Chen F, Dai Z, Huang C, Chen H, Wang X, Li X. Gastrointestinal Disease and COVID-19: A Review of Current Evidence. Dig Dis 2022;40:506-14. [PMID: 34510032 DOI: 10.1159/000519412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
254 Mateen BA, Samanta S, Tullie S, O'Neill S, Cargill Z, Kelly G, Brennan E, Patel M, Al-Agil M, Galloway J, Teo J, Shawcross DL, Kent AJ, Hayee B. Diarrhoea and preadmission antibiotic exposure in COVID-19: a retrospective cohort study of 1153 hospitalised patients. BMJ Open Gastroenterol 2021;8:e000593. [PMID: 34489301 DOI: 10.1136/bmjgast-2020-000593] [Reference Citation Analysis]
255 Viganò C, Mulinacci G, Palermo A, Barisani D, Pirola L, Fichera M, Invernizzi P, Massironi S. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future. World J Gastroenterol 2021; 27(33): 5520-5535 [PMID: 34588749 DOI: 10.3748/wjg.v27.i33.5520] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
256 Almuzaini Y, Alsohime F, Subaie SA, Temsah MH, Alsofayan Y, Alamri F, Alahmari A, Alahdal H, Sonbol H, Almaghrabi R, Nahhas M, Khan A. Clinical profiles associated with SARS-CoV-2 infection and complications from coronavirus disease-2019 in children from a national registry in Saudi Arabia. Ann Thorac Med 2021;16:280-6. [PMID: 34484444 DOI: 10.4103/atm.atm_709_20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
257 Becchetti C, Gschwend SG, Dufour JF, Banz V. COVID-19 in Liver Transplant Recipients: A Systematic Review. J Clin Med 2021;10:4015. [PMID: 34501463 DOI: 10.3390/jcm10174015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
258 Attah E, Martin TA, Smith ES, Tewani S, Hajifathalian K, Sharaiha RZ, Crawford CV, Wan D. Observed risk of recurrent bleeding and thromboembolic disease in COVID-19 patients with gastrointestinal bleeding. Endosc Int Open 2021;9:E1435-44. [PMID: 34466370 DOI: 10.1055/a-1497-1801] [Reference Citation Analysis]
259 Grinevich VB, Kravchuk YA. Diseases of the digestive organs and COVID-19. Russian Military Medical Academy Reports 2021;40:39-44. [DOI: 10.17816/rmmar76269] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
260 Phipps MM, Verna EC. Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. Liver Transpl 2021;27:1312-25. [PMID: 34096188 DOI: 10.1002/lt.26194] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
261 Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int 2021;41:1988-98. [PMID: 34152690 DOI: 10.1111/liv.14984] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
262 Lipták P, Banovčin P, Rosoľanka R, Prokopič M, Kocan I, Žiačikova I, Uhrík P, Grendár M, Hyrdel R. A machine learning approach for identification of gastrointestinal predictors for the risk of COVID-19 related hospitalization.. [DOI: 10.1101/2021.08.27.21262728] [Reference Citation Analysis]
263 Norsa L, Bonaffini PA, Caldato M, Bonifacio C, Sonzogni A, Indriolo A, Valle C, Furfaro F, Bonanomi A, Franco PN, Gori M, Smania V, Scaramella L, Forzenigo L, Vecchi M, Solbiati M, Costantino G, Danese S, D'Antiga L, Sironi S, Elli L. Intestinal ischemic manifestations of SARS-CoV-2: Results from the ABDOCOVID multicentre study. World J Gastroenterol 2021; 27(32): 5448-5459 [PMID: 34539144 DOI: 10.3748/wjg.v27.i32.5448] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
264 Nassar IO, Langman G, Quraishi MN, Sharma N. SARS-CoV-2-triggered lymphocytic colitis. BMJ Case Rep 2021;14:e243003. [PMID: 34429288 DOI: 10.1136/bcr-2021-243003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
265 Merino JJ, Macho-González A, Benedi J, González MP. Neurological manifestations of COVID-19 in patients: from path physiology to therapy. Neurol Sci 2021;42:4867-79. [PMID: 34417704 DOI: 10.1007/s10072-021-05505-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
266 Güneysu F, Durmuş E, Yurumez Y. COVID-19 Pandemisinde Acil Servise Başvuran Hastaların Kan Parametrelerinin Hastalığı Öngörmedeki Başarısının Değerlendirilmesi. Sakarya Medical Journal 2021. [DOI: 10.31832/smj.930242] [Reference Citation Analysis]
267 Du M, Yang DS, Liu M, Liu J. COVID-19 and Liver dysfunction: Epidemiology, Association and Potential Mechanisms. Clin Res Hepatol Gastroenterol 2021;:101793. [PMID: 34428501 DOI: 10.1016/j.clinre.2021.101793] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
268 Rehman MFU, Akhter S, Batool AI, Selamoglu Z, Sevindik M, Eman R, Mustaqeem M, Akram MS, Kanwal F, Lu C, Aslam M. Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World. Antibiotics (Basel) 2021;10:1011. [PMID: 34439061 DOI: 10.3390/antibiotics10081011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
269 Arora G, Joshi J, Mandal RS, Shrivastava N, Virmani R, Sethi T. Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19. Pathogens 2021;10:1048. [PMID: 34451513 DOI: 10.3390/pathogens10081048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
270 Arora G, Joshi J, Mandal RS, Shrivastava N, Virmani R, Sethi T. Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19. Pathogens 2021;10:1048. [PMID: 34451513 DOI: 10.3390/pathogens10081048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
271 Ianushevich OO, Maev IV, Krikheli NI, Levchenko OV, Rogova IV, Zaborovskii AV, Andreev DN, Kebina AL, Bordin DS, Bakulin IG, Bakulina NV, Andreev NG, Asadulin PO, Bagdasarian AS, Devkota MK, Evarnitskaia NR, Krikunova OV, Kucher SA, Sokolov FS, Fomenko AK, Khar'kovskii VA, Sharina IA. Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic. Terapevticheskii arkhiv 2021;93:853-861. [DOI: 10.26442/00403660.2021.08.200977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
272 Velikova T, Snegarova V, Kukov A, Batselova H, Mihova A, Nakov R. Gastrointestinal mucosal immunity and COVID-19. World J Gastroenterol 2021; 27(30): 5047-5059 [PMID: 34497434 DOI: 10.3748/wjg.v27.i30.5047] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
273 Buoite Stella A, Furlanis G, Frezza NA, Valentinotti R, Ajcevic M, Manganotti P. Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study. J Neurol 2021. [PMID: 34386903 DOI: 10.1007/s00415-021-10735-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
274 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
275 Park JG, Oladunni FS, Rohaim MA, Whittingham-Dowd J, Tollitt J, Hodges MDJ, Fathallah N, Assas MB, Alhazmi W, Almilaibary A, Iqbal M, Chang P, Escalona R, Shivanna V, Torrelles JB, Worthington JJ, Jackson-Jones LH, Martinez-Sobrido L, Munir M. Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2. iScience 2021;24:102941. [PMID: 34368648 DOI: 10.1016/j.isci.2021.102941] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
276 Iftikhar H, Najam M, Rehman MU. Mesenteric Lymphadenitis Due to COVID-19 in an Adult. Cureus 2021;13:e15897. [PMID: 34336415 DOI: 10.7759/cureus.15897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
277 Santos HO. Therapeutic supplementation with zinc in the management of COVID-19-related diarrhea and ageusia/dysgeusia: mechanisms and clues for a personalized dosage regimen. Nutr Rev 2021:nuab054. [PMID: 34338769 DOI: 10.1093/nutrit/nuab054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
278 Antunes de Brito CA, de Oliveira Filho JRB, Marques DT, Lencastre MDC, de Almeida JR, Lopes EP. COVID-19 and Hepatic Artery Thrombosis: A Case Report. Am J Case Rep 2021;22:e932531. [PMID: 34333508 DOI: 10.12659/AJCR.932531] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
279 Brady M, Combs A, Venkatraman C, Solorzano A, Johnson A, Mcquaid C, Rahman A, Leyva H, Edmund Kwok W, Wood RW, Deane R. Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2.. [DOI: 10.1101/2021.07.30.454520] [Reference Citation Analysis]
280 Zhang T, Liu D, Tian D, Xia L. The roles of nausea and vomiting in COVID-19: did we miss something? J Microbiol Immunol Infect 2021;54:541-6. [PMID: 34435559 DOI: 10.1016/j.jmii.2020.10.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
281 Tarik A, Soukaina R, Samir M, Asmae S, Ahlame B, Rida B, Yasser A, Ilham E, Noureddine E, Hassan S, Ahmed B. Gastrointestinal manifestations during COVID-19 virus infection: A Moroccan prospective study. Arab J Gastroenterol 2021:S1687-1979(21)00064-2. [PMID: 34509387 DOI: 10.1016/j.ajg.2021.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
282 Xia S, Lan Q, Zhu Y, Wang C, Xu W, Li Y, Wang L, Jiao F, Zhou J, Hua C, Wang Q, Cai X, Wu Y, Gao J, Liu H, Sun G, Münch J, Kirchhoff F, Yuan Z, Xie Y, Sun F, Jiang S, Lu L. Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation. Signal Transduct Target Ther 2021;6:288. [PMID: 34326308 DOI: 10.1038/s41392-021-00712-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
283 C. Gaze D. Coronavirus Disease: Epidemiology, Aetiology, Pathophysiology and Involvement of the Cardiovascular System. Cardiac Diseases - Novel Aspects of Cardiac Risk, Cardiorenal Pathology and Cardiac Interventions 2021. [DOI: 10.5772/intechopen.98210] [Reference Citation Analysis]
284 Pirola L, Palermo A, Mulinacci G, Ratti L, Fichera M, Invernizzi P, Viganò C, Massironi S. Acute mesenteric ischemia and small bowel imaging findings in COVID-19: A comprehensive review of the literature. World J Gastrointest Surg 2021; 13(7): 702-716 [PMID: 34354803 DOI: 10.4240/wjgs.v13.i7.702] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
285 Moreira-Rosário A, Marques C, Pinheiro H, Araújo JR, Ribeiro P, Rocha R, Mota I, Pestana D, Ribeiro R, Pereira A, de Sousa MJ, Pereira-Leal J, de Sousa J, Morais J, Teixeira D, Rocha JC, Silvestre M, Príncipe N, Gatta N, Amado J, Santos L, Maltez F, Boquinhas A, de Sousa G, Germano N, Sarmento G, Granja C, Póvoa P, Faria A, Calhau C. Gut Microbiota Diversity and C-Reactive Protein Are Predictors of Disease Severity in COVID-19 Patients. Front Microbiol 2021;12:705020. [PMID: 34349747 DOI: 10.3389/fmicb.2021.705020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
286 Hensley-McBain T, Manuzak JA. Zonulin as a biomarker and potential therapeutic target in multisystem inflammatory syndrome in children. J Clin Invest 2021;131:151467. [PMID: 34160366 DOI: 10.1172/JCI151467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
287 Yousof SM, Tanvir I, Kolieb E, Atta R. Work Stress, Dysbiosis, and Immune Dysregulation: The Interconnected Triad in COVID-19 Infection in the Medical Team Staff - A Mini-Review. J Microsc Ultrastruct 2022;10:147-53. [PMID: 36687328 DOI: 10.4103/jmau.jmau_9_21] [Reference Citation Analysis]
288 Evseeva GP, Telepneva RS, Knizhnikova EV, Suprun SV, Pichugina SV, Yakovlev EI, Galyant OI, Kozlov VK, Lebed’ko OA. COVID-19 in pediatric population. Bûlletenʹ fiziologii i patologii dyhaniâ 2021. [DOI: 10.36604/1998-5029-2021-80-100-114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
289 Pott-Junior H, Bittencourt NQP, Chacha SFG, Luporini RL, Cominetti MR, Anibal FF. Elevations in Liver Transaminases in COVID-19: (How) Are They Related? Front Med (Lausanne) 2021;8:705247. [PMID: 34336904 DOI: 10.3389/fmed.2021.705247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
290 Jia L, Weng S, Wu J, Tian X, Zhang Y, Wang X, Wang J, Yan D, Wang W, Fang F, Zhu Z, Qiu C, Zhang W, Xu Y, Wan Y. Pre-existing antibodies targeting a linear epitope on SARS-CoV-2 S2 cross-reacted with commensal gut bacteria and shaped vaccine induced immunity.. [DOI: 10.1101/2021.07.13.21260404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
291 Schulz C, Mayerle J, Lerch MM, Malfertheiner P. [Update 2021: COVID-19 from the perspective of gastroenterology]. Dtsch Med Wochenschr 2021;146:891-3. [PMID: 34256402 DOI: 10.1055/a-1449-4054] [Reference Citation Analysis]
292 Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
293 Liu J, Wang T, Cai Q, Huang D, Sun L, He Q, Wang FS, Chen J. Acute Kidney Injury and Early Predictive Factors in COVID-19 Patients. Front Med (Lausanne) 2021;8:604242. [PMID: 34322497 DOI: 10.3389/fmed.2021.604242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
294 Tribolet L, Alexander MR, Brice AM, van Vuren PJ, Rootes CL, Mara K, McDonald M, Bruce KL, Gough TJ, Shi S, Cowled C, Bean AGD, Stewart CR. ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2. J Virol 2021;95:e0032721. [PMID: 33963054 DOI: 10.1128/JVI.00327-21] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
295 Hassan AO, Shrihari S, Gorman MJ, Ying B, Yaun D, Raju S, Chen RE, Dmitriev IP, Kashentseva E, Adams LJ, Mann C, Davis-Gardner ME, Suthar MS, Shi PY, Saphire EO, Fremont DH, Curiel DT, Alter G, Diamond MS. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice. Cell Rep 2021;36:109452. [PMID: 34289385 DOI: 10.1016/j.celrep.2021.109452] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 19.5] [Reference Citation Analysis]
296 Dai Y, Zhao Z, Zhou H, Huang D, Luo J, Zhang C, Chen Q, Chen X, Yao Y, Jiang X, Cheng J. Traditional Chinese Medicine Enema Therapy in a Patient With a Confirmed Negative SARS-CoV-2 Test in the Respiratory Tract but Positive in the Intestinal Tract: A Case Report. Front Public Health 2021;9:687283. [PMID: 34307281 DOI: 10.3389/fpubh.2021.687283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
297 Amjad W, Haider R, Malik A, Qureshi W. Insights into the management of anorectal disease in the coronavirus 2019 disease era. Therap Adv Gastroenterol 2021;14:17562848211028117. [PMID: 34290826 DOI: 10.1177/17562848211028117] [Reference Citation Analysis]
298 Kumric M, Ticinovic Kurir T, Martinovic D, Zivkovic PM, Bozic J. Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence. World J Gastroenterol 2021; 27(25): 3748-3761 [PMID: 34321841 DOI: 10.3748/wjg.v27.i25.3748] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
299 Fang LG, Zhou Q. Remarkable gastrointestinal and liver manifestations of COVID-19: A clinical and radiologic overview. World J Clin Cases 2021; 9(19): 4969-4979 [PMID: 34307547 DOI: 10.12998/wjcc.v9.i19.4969] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
300 Finsterer J, Scorza FA, Scorza CA, Fiorini AC. Extrapulmonary onset manifestations of COVID-19. Clinics (Sao Paulo) 2021;76:e2900. [PMID: 34231709 DOI: 10.6061/clinics/2021/e2900] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
301 Laszkowska M, Faye AS, Kim J, Truong H, Silver ER, Ingram M, May B, Ascherman B, Bartram L, Zucker J, Sobieszczyk ME, Abrams JA, Lebwohl B, Freedberg DE, Hur C. Disease Course and Outcomes of COVID-19 Among Hospitalized Patients With Gastrointestinal Manifestations. Clin Gastroenterol Hepatol 2021;19:1402-1409.e1. [PMID: 33007514 DOI: 10.1016/j.cgh.2020.09.037] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
302 Elmunzer BJ, Spitzer RL, Foster LD, Merchant AA, Howard EF, Patel VA, West MK, Qayed E, Nustas R, Zakaria A, Piper MS, Taylor JR, Jaza L, Forbes N, Chau M, Lara LF, Papachristou GI, Volk ML, Hilson LG, Zhou S, Kushnir VM, Lenyo AM, Mcleod CG, Amin S, Kuftinec GN, Yadav D, Fox C, Kolb JM, Pawa S, Pawa R, Canakis A, Huang C, Jamil LH, Aneese AM, Glamour BK, Smith ZL, Hanley KA, Wood J, Patel HK, Shah JN, Agarunov E, Sethi A, Fogel EL, Mcnulty G, Haseeb A, Trieu JA, Dixon RE, Yang JY, Mendelsohn RB, Calo D, Aroniadis OC, Lacomb JF, Scheiman JM, Sauer BG, Dang DT, Piraka CR, Shah ED, Pohl H, Tierney WM, Mitchell S, Condon A, Lenhart A, Dua KS, Kanagala VS, Kamal A, Singh VK, Pinto-sanchez MI, Hutchinson JM, Kwon RS, Korsnes SJ, Singh H, Solati Z, Willingham FF, Yachimski PS, Conwell DL, Mosier E, Azab M, Patel A, Buxbaum J, Wani S, Chak A, Hosmer AE, Keswani RN, Dimaio CJ, Bronze MS, Muthusamy R, Canto MI, Gjeorgjievski VM, Imam Z, Odish F, Edhi AI, Orosey M, Tiwari A, Patwardhan S, Brown NG, Patel AA, Ordiah CO, Sloan IP, Cruz L, Koza CL, Okafor U, Hollander T, Furey N, Reykhart O, Zbib NH, Damianos JA, Esteban J, Hajidiacos N, Saul M, Mays M, Anderson G, Wood K, Mathews L, Diakova G, Caisse M, Wakefield L, Nitchie H, Waljee AK, Tang W, Zhang Y, Zhu J, Deshpande AR, Rockey DC, Alford TB, Durkalski V. Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019. Clinical Gastroenterology and Hepatology 2021;19:1355-1365.e4. [DOI: 10.1016/j.cgh.2020.09.041] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 18.5] [Reference Citation Analysis]
303 Sofi-Mahmudi A. Patients with COVID-19 may present some oral manifestations. Evid Based Dent 2021;22:80-1. [PMID: 34172917 DOI: 10.1038/s41432-021-0173-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
304 Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front Immunol 2021;12:686029. [PMID: 34276671 DOI: 10.3389/fimmu.2021.686029] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 26.0] [Reference Citation Analysis]
305 Vaidya T, Nanivadekar A, Patel R. Imaging spectrum of abdominal manifestations of COVID-19. World J Radiol 2021; 13(6): 157-170 [PMID: 34249237 DOI: 10.4329/wjr.v13.i6.157] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
306 Cao TT, Zhang GQ, Pellegrini E, Zhao Q, Li J, Luo LJ, Pan HQ. COVID-19 and its effects on the digestive system. World J Gastroenterol 2021; 27(24): 3502-3515 [PMID: 34239265 DOI: 10.3748/wjg.v27.i24.3502] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
307 Sideris GA, Nikolakea M, Karanikola A, Konstantinopoulou S, Giannis D, Modahl L. Imaging in the COVID-19 era: Lessons learned during a pandemic. WJR 2021;13:193-223. [DOI: 10.4329/wjr.v13.i6.193] [Reference Citation Analysis]
308 Sideris GA, Nikolakea M, Karanikola AE, Konstantinopoulou S, Giannis D, Modahl L. Imaging in the COVID-19 era: Lessons learned during a pandemic. World J Radiol 2021; 13(6): 192-222 [PMID: 34249239 DOI: 10.4329/wjr.v13.i6.192] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
309 Correia de Sá T, Soares C, Rocha M. Acute pancreatitis and COVID-19: A literature review. World J Gastrointest Surg 2021; 13(6): 574-584 [PMID: 34194615 DOI: 10.4240/wjgs.v13.i6.574] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
310 Ealey KN, Phillips J, Sung HK. COVID-19 and obesity: fighting two pandemics with intermittent fasting. Trends Endocrinol Metab 2021;32:706-20. [PMID: 34275726 DOI: 10.1016/j.tem.2021.06.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
311 Ali MR, Hasan MA, Rahman MS, Billah M, Karmakar S, Shimu AS, Hossain MF, Maruf MMH, Rahman MS, Saju MSR, Hasan MR, Acharjee UK, Hasan MF. Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience. J Infect Public Health 2021:S1876-0341(21)00177-5. [PMID: 34215560 DOI: 10.1016/j.jiph.2021.06.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
312 Haghani M, Varamini P. Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature. Scientometrics 2021;:1-46. [PMID: 34188334 DOI: 10.1007/s11192-021-04036-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
313 Bubnova MG, Shliakhto EV, Aronov DM, Belevskii AS, Gerasimenko MI, Glezer MG, Gordeev MN, Drapkina OM, Ivanova GE, Ioseliani DG, Karamnova NS, Kosmacheva ED, Kuleshov AV, Kukshina AA, Liadov KV, Liamina NP, Meshcheriakova NN, Makarova MR, Nikitiuk DB, Pasechnik IN, Persiianova-dubrova AL, Pogonchenkova IV, Svet AV, Starodubova AV, Tutel'ian VA. Novel сoronavirus infectious disease COVID-19: features of comprehensive cardiac and respiratory rehabilitation. CardioSomatics 2021;12:64-101. [DOI: 10.26442/22217185.2021.2.200840] [Reference Citation Analysis]
314 Groff A, Kavanaugh M, Ramgobin D, McClafferty B, Aggarwal CS, Golamari R, Jain R. Gastrointestinal Manifestations of COVID-19: A Review of What We Know. Ochsner J 2021;21:177-80. [PMID: 34239378 DOI: 10.31486/toj.20.0086] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
315 Farooq A, Alam F, Saeed A, Butt F, Khaliq MA, Malik A, Chaudhry M, Abdullah M. Multisystem Inflammatory Syndrome in Children and Adolescents (MIS-C) under the Setting of COVID-19: A Review of Clinical Presentation, Workup and Management. Infect Dis (Auckl) 2021;14:11786337211026642. [PMID: 34220204 DOI: 10.1177/11786337211026642] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
316 Trivedi HD, Wilechansky R, Goyes D, Vieira Barbosa J, Canakis A, Lai M, Long MT, Fricker Z. Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19. Gastroenterology Res 2021;14:179-83. [PMID: 34267833 DOI: 10.14740/gr1389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
317 Volkan E. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era. Mol Biotechnol 2021. [PMID: 34145550 DOI: 10.1007/s12033-021-00353-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
318 Dergham J, Delerce J, Bedotto M, La Scola B, Moal V. Isolation of Viable SARS-CoV-2 Virus from Feces of an Immunocompromised Patient Suggesting a Possible Fecal Mode of Transmission. J Clin Med 2021;10:2696. [PMID: 34207314 DOI: 10.3390/jcm10122696] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
319 D'Amico FE, Glavas D, Noaro G, Bassi D, Boetto R, Gringeri E, De Luca M, Cillo U. Case Report: Liver Cysts and SARS-CoV-2: No Evidence of Virus in Cystic Fluid. Front Surg 2021;8:677889. [PMID: 34222319 DOI: 10.3389/fsurg.2021.677889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
320 Liu S, Tang MM, Du J, Gong ZC, Sun SS. COVID-19 in gastroenterology and hepatology: Lessons learned and questions to be answered. World J Clin Cases 2021; 9(17): 4199-4209 [PMID: 34141782 DOI: 10.12998/wjcc.v9.i17.4199] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
321 Shahani D, Farouq ZS, Galadima H, Khare A, Ravi N. Survey of COVID-19 associated symptoms and reported deaths in an urban community in Kano, Nigeria.. [DOI: 10.1101/2021.06.14.21258236] [Reference Citation Analysis]
322 Bubnova MG, Shlyakhto EV, Aronov DM, Belevsky AS, Gerasimenko MY, Glezer MG, Gordeev MN, Drapkina OM, Ivanova GE, Ioseliani DG, Karamnova NS, Kosmacheva ED, Kuleshov AV, Kukshina AA, Lyadov KV, Lyamina NP, Makarova MR, Meshcheryakova NN, Nikityuk DB, Pasechnik IN, Persiyanova-dubrova AL, Pogonchenkova IV, Svet AV, Starodubova AV, Tutelian VA. Coronavirus disease 2019: features of comprehensive cardiac and pulmonary rehabilitation. Russ J Cardiol 2021;26:4487. [DOI: 10.15829/1560-4071-2021-4487] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
323 Giron LB, Dweep H, Yin X, Wang H, Damra M, Goldman AR, Gorman N, Palmer CS, Tang HY, Shaikh MW, Forsyth CB, Balk RA, Zilberstein NF, Liu Q, Kossenkov A, Keshavarzian A, Landay A, Abdel-Mohsen M. Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Front Immunol 2021;12:686240. [PMID: 34177935 DOI: 10.3389/fimmu.2021.686240] [Cited by in Crossref: 41] [Cited by in F6Publishing: 50] [Article Influence: 20.5] [Reference Citation Analysis]
324 Lv Y, Zhao X, Wang Y, Zhu J, Ma C, Feng X, Ma Y, Zheng Y, Yang L, Han G, Xie H. Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19. Front Med (Lausanne) 2021;8:639855. [PMID: 34179034 DOI: 10.3389/fmed.2021.639855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
325 Yu D, Du Q, Yan S, Guo XG, He Y, Zhu G, Zhao K, Ouyang S. Liver injury in COVID-19: clinical features and treatment management. Virol J 2021;18:121. [PMID: 34108015 DOI: 10.1186/s12985-021-01593-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
326 Bende F, Tudoran C, Sporea I, Fofiu R, Bâldea V, Cotrău R, Popescu A, Sirli R, Ungureanu BS, Tudoran M. A Multidisciplinary Approach to Evaluate the Presence of Hepatic and Cardiac Abnormalities in Patients with Post-Acute COVID-19 Syndrome-A Pilot Study. J Clin Med 2021;10:2507. [PMID: 34204032 DOI: 10.3390/jcm10112507] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
327 Miyara SJ, Becker LB, Guevara S, Kirsch C, Metz CN, Shoaib M, Grodstein E, Nair VV, Jandovitz N, McCann-Molmenti A, Hayashida K, Takegawa R, Shinozaki K, Yagi T, Aoki T, Nishikimi M, Choudhary RC, Cho YM, Zanos S, Zafeiropoulos S, Hoffman HB, Watt S, Lumermann CM, Aronsohn J, Shore-Lesserson L, Molmenti EP. Pneumatosis Intestinalis in the Setting of COVID-19: A Single Center Case Series From New York. Front Med (Lausanne) 2021;8:638075. [PMID: 34150792 DOI: 10.3389/fmed.2021.638075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
328 Crea F, Panfili FM, Amodeo ME, Fintini D, Rossi FP, Trenta I, Menichella A, Ossella C, Deidda A, Lidano R, Macchiarulo G, Lambiase C, Barbieri MA, Raponi M. The impact of National Containment Measures on a Pediatric Italian regional Hub for COVID-19, an observational study. Ital J Pediatr 2021;47:122. [PMID: 34078423 DOI: 10.1186/s13052-021-01081-w] [Reference Citation Analysis]
329 Ahmed A, Fisher JC, Pochapin MB, Freedman SD, Kothari DJ, Shah PC, Sheth SG. Hyperlipasemia in absence of acute pancreatitis is associated with elevated D-dimer and adverse outcomes in COVID 19 disease. Pancreatology 2021;21:698-703. [PMID: 33741267 DOI: 10.1016/j.pan.2021.02.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
330 Pandanaboyana S, Moir J, Leeds JS, Oppong K, Kanwar A, Marzouk A, Belgaumkar A, Gupta A, Siriwardena AK, Haque AR, Awan A, Balakrishnan A, Rawashdeh A, Ivanov B, Parmar C, M Halloran C, Caruana C, Borg CM, Gomez D, Damaskos D, Karavias D, Finch G, Ebied H, K Pine J, R A Skipworth J, Milburn J, Latif J, Ratnam Apollos J, El Kafsi J, Windsor JA, Roberts K, Wang K, Ravi K, V Coats M, Hollyman M, Phillips M, Okocha M, Sj Wilson M, A Ameer N, Kumar N, Shah N, Lapolla P, Magee C, Al-Sarireh B, Lunevicius R, Benhmida R, Singhal R, Balachandra S, Demirli Atıcı S, Jaunoo S, Dwerryhouse S, Boyce T, Charalampakis V, Kanakala V, Abbas Z, Nayar M; COVID PAN collaborative group. SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study. Gut 2021;70:1061-9. [PMID: 33547182 DOI: 10.1136/gutjnl-2020-323364] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 19.5] [Reference Citation Analysis]
331 Herta T, Berg T. COVID-19 and the liver - Lessons learned. Liver Int 2021;41 Suppl 1:1-8. [PMID: 34155789 DOI: 10.1111/liv.14854] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
332 Livanos AE, Jha D, Cossarini F, Gonzalez-Reiche AS, Tokuyama M, Aydillo T, Parigi TL, Ladinsky MS, Ramos I, Dunleavy K, Lee B, Dixon RE, Chen ST, Martinez-Delgado G, Nagula S, Bruce EA, Ko HM, Glicksberg BS, Nadkarni G, Pujadas E, Reidy J, Naymagon S, Grinspan A, Ahmad J, Tankelevich M, Bram Y, Gordon R, Sharma K, Houldsworth J, Britton GJ, Chen-Liaw A, Spindler MP, Plitt T, Wang P, Cerutti A, Faith JJ, Colombel JF, Kenigsberg E, Argmann C, Merad M, Gnjatic S, Harpaz N, Danese S, Cordon-Cardo C, Rahman A, Schwartz RE, Kumta NA, Aghemo A, Bjorkman PJ, Petralia F, van Bakel H, Garcia-Sastre A, Mehandru S. Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms. Gastroenterology 2021;160:2435-2450.e34. [PMID: 33676971 DOI: 10.1053/j.gastro.2021.02.056] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 30.0] [Reference Citation Analysis]
333 Heustess AM, Allard MA, Thompson DK, Fasinu PS. Clinical Management of COVID-19: A Review of Pharmacological Treatment Options. Pharmaceuticals (Basel) 2021;14:520. [PMID: 34071185 DOI: 10.3390/ph14060520] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
334 Leowattana W. Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients. World J Virol 2021; 10(3): 86-96 [PMID: 34079691 DOI: 10.5501/wjv.v10.i3.86] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
335 Acharya R, Poudel D, Bowers R, Patel A, Schultz E, Bourgeois M, Paswan R, Stockholm S, Batten M, Kafle S, Lonial K, Locklear I. Low Serum Albumin Predicts Severe Outcomes in COVID-19 Infection: A Single-Center Retrospective Case-Control Study. J Clin Med Res 2021;13:258-67. [PMID: 34104277 DOI: 10.14740/jocmr4507] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
336 Grinevich VB, Kravchuk YA, Ped VI, Sas EI, Salikova SP, Gubonina IV, Tkachenko EI, Sitkin SI, Lazebnik LB, Golovanova EV, Belousova EA, Makarchuk PA, Eremina EY, Sarsenbaeva AS, Abdulganieva DI, Tarasova LV, Gromova OA, Ratnikov VA, Kozlov KV, Ratnikova AK. Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientific medical society of internal medicine (RSMSIM) and the Gastroenterological Scientific Society of Russia (2nd edition). jour 2021. [DOI: 10.31146/1682-8658-ecg-187-3-5-82] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
337 Mahmoud IS, Jarrar YB. Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges. Mol Biol Rep 2021;48:4667-75. [PMID: 34023987 DOI: 10.1007/s11033-021-06390-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
338 Bzeizi K, Abdulla M, Mohammed N, Alqamish J, Jamshidi N, Broering D. Effect of COVID-19 on liver abnormalities: a systematic review and meta-analysis. Sci Rep 2021;11:10599. [PMID: 34012016 DOI: 10.1038/s41598-021-89513-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
339 Nashiry MA, Sumi SS, Sharif Shohan MU, Alyami SA, Azad AKM, Moni MA. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders. Brief Bioinform 2021:bbab126. [PMID: 33993223 DOI: 10.1093/bib/bbab126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
340 Hassan AO, Shrihari S, Gorman MJ, Ying B, Yuan D, Raju S, Chen RE, Dmitriev IP, Kashentseva E, Adams LJ, Shi P, Fremont DH, Curiel DT, Alter G, Diamond MS. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice.. [DOI: 10.1101/2021.05.08.443267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
341 Honeyford K, Coughlan C, Nijman RG, Expert P, Burcea G, Maconochie I, Kinderlerer A, Cooke GS, Costelloe CE. Changes in Emergency Department Activity and the First COVID-19 Lockdown: A Cross-sectional Study. West J Emerg Med 2021;22:603-7. [PMID: 34125034 DOI: 10.5811/westjem.2021.2.49614] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
342 Brannagan TH 3rd, Auer-Grumbach M, Berk JL, Briani C, Bril V, Coelho T, Damy T, Dispenzieri A, Drachman BM, Fine N, Gaggin HK, Gertz M, Gillmore JD, Gonzalez E, Hanna M, Hurwitz DR, Khella SL, Maurer MS, Nativi-Nicolau J, Olugemo K, Quintana LF, Rosen AM, Schmidt HH, Shehata J, Waddington-Cruz M, Whelan C, Ruberg FL. ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable. Orphanet J Rare Dis 2021;16:204. [PMID: 33957949 DOI: 10.1186/s13023-021-01834-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
343 Kadali RAK, Janagama R, Peruru S, Gajula V, Madathala RR, Chennaiahgari N, Malayala SV. Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. J Med Virol 2021;93:4420-9. [PMID: 33822361 DOI: 10.1002/jmv.26996] [Cited by in Crossref: 62] [Cited by in F6Publishing: 70] [Article Influence: 31.0] [Reference Citation Analysis]
344 Del Nonno F, Nardacci R, Colombo D, Visco-Comandini U, Cicalini S, Antinori A, Marchioni L, D'Offizi G, Piacentini M, Falasca L. Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger? Cells 2021;10:1103. [PMID: 34064487 DOI: 10.3390/cells10051103] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
345 Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne) 2021;8:653516. [PMID: 34017846 DOI: 10.3389/fmed.2021.653516] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 36.0] [Reference Citation Analysis]
346 Capaccione KM, Yang H, West E, Patel H, Ma H, Patel S, Fruauff A, Loeb G, Maddocks A, Borowski A, Lala S, Nguyen P, Lignelli A, D'souza B, Desperito E, Ruzal-Shapiro C, Salvatore MM. Pathophysiology and Imaging Findings of COVID-19 Infection: An Organ-system Based Review. Acad Radiol 2021;28:595-607. [PMID: 33583712 DOI: 10.1016/j.acra.2021.01.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
347 Leal T, Costa E, Arroja B, Gonçalves R, Alves J. Gastrointestinal manifestations of COVID-19: results from a European centre. Eur J Gastroenterol Hepatol 2021;33:691-4. [PMID: 33787540 DOI: 10.1097/MEG.0000000000002152] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
348 Afshar-Oromieh A, Prosch H, Schaefer-Prokop C, Bohn KP, Alberts I, Mingels C, Thurnher M, Cumming P, Shi K, Peters A, Geleff S, Lan X, Wang F, Huber A, Gräni C, Heverhagen JT, Rominger A, Fontanellaz M, Schöder H, Christe A, Mougiakakou S, Ebner L. A comprehensive review of imaging findings in COVID-19 - status in early 2021. Eur J Nucl Med Mol Imaging 2021;48:2500-24. [PMID: 33932183 DOI: 10.1007/s00259-021-05375-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
349 Hussein NR, Rashad BH, Almizori LA, Yousif SS, Sadeeq AT, Abdulkareem YR, Mahmood AM, Salih ZK. The Risk of SARS-CoV-2 Reinfection in Duhok city, Kurdistan Region of Iraq. Mediterr J Hematol Infect Dis 2021;13:e2021035. [PMID: 34007423 DOI: 10.4084/MJHID.2021.035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
350 Varshney R, Bansal N, Khanduri A, Gupta J, Gupta R. Colonic Gangrene: A Sequela of Coronavirus Disease 2019. Cureus 2021;13:e14687. [PMID: 34055531 DOI: 10.7759/cureus.14687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
351 Wong TL, Weitzer DJ. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina (Kaunas) 2021;57:418. [PMID: 33925784 DOI: 10.3390/medicina57050418] [Cited by in Crossref: 5] [Cited by in F6Publishing: 91] [Article Influence: 2.5] [Reference Citation Analysis]
352 Lee YR. Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic. Korean J Gastroenterol 2021;77:156-9. [DOI: 10.4166/kjg.2021.402] [Reference Citation Analysis]
353 Moreira-rosário A, Marques C, Pinheiro H, Araújo JR, Ribeiro P, Rocha R, Mota I, Pestana D, Ribeiro R, Pereira A, de Sousa MJ, Pereira-leal J, de Sousa J, Morais J, Teixeira D, Rocha JC, Silvestre M, Príncipe N, Gatta N, Amado J, Santos L, Maltez F, Boquinhas A, de Sousa G, Germano N, Sarmento G, Granja C, Póvoa P, Faria A, Calhau C. Gut microbiota diversity and C-Reactive Protein are predictors of disease severity in COVID-19 patients.. [DOI: 10.1101/2021.04.20.440658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
354 Tariq R, Saha S, Furqan F, Pardi D, Khanna S. In reply-Lack of Marked Association Between Gastrointestinal Symptoms and COVID-19 Mortality: An Updated Meta-analysis Based on Adjusted Effect Estimates. Mayo Clin Proc 2021;96:1680-1. [PMID: 34088426 DOI: 10.1016/j.mayocp.2021.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
355 Xu W, Huang C, Fei L, Li Q, Chen L. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study. Clin Interv Aging 2021;16:675-85. [PMID: 33911856 DOI: 10.2147/CIA.S303629] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
356 Lim ZY, Ang AXY, Cross GB. COVID-19 associated parotitis. IDCases 2021;24:e01122. [PMID: 33898261 DOI: 10.1016/j.idcr.2021.e01122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
357 Deane K, Singh A, Sarfraz A, Sarfraz Z, Ciccone L, Zheng B, Afzal A, Khan G, Rodriguez G, Bahtiyar G. Correlation of Severity of COVID-19 Disease With Gastrointestinal Manifestations and Liver Injury - A North Brooklyn Community Hospital Experience: A Retrospective Cohort Study. Cureus 2021;13:e14543. [PMID: 34017658 DOI: 10.7759/cureus.14543] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
358 Mnatsakanyan MG, Pogromov AP, Lishuta AS, Fomin VV, Volkova OS, Tashchyan OV, Kuprina IV, Shumskaya YF. Liver and COVID-19: possible mechanisms of damage. Terapevticheskii arkhiv 2021;93:427-30. [DOI: 10.26442/00403660.2021.04.200733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
359 Saxena RK, Indrani C, Ramani MV. Bowel Perforation due to COVID-19: A Mini Review. Journal of South Asian Federation of Obstetrics and Gynaecology 2021;12:427-431. [DOI: 10.5005/jp-journals-10006-1845] [Reference Citation Analysis]
360 Shen JJ. Psychosocio-economic impacts of COVID-19 on gastroenterology and endoscopy practice. Gastroenterol Rep (Oxf) 2021;9:205-11. [PMID: 34312585 DOI: 10.1093/gastro/goab012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
361 Spielberger BD, Goerne T, Geweniger A, Henneke P, Elling R. Intra-Household and Close-Contact SARS-CoV-2 Transmission Among Children - a Systematic Review. Front Pediatr 2021;9:613292. [PMID: 33898355 DOI: 10.3389/fped.2021.613292] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
362 Brooks EF, Bhatt AS. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19? Cold Spring Harb Mol Case Stud 2021;7:a006031. [PMID: 33593727 DOI: 10.1101/mcs.a006031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
363 Aldhahri M, Alghamdi R. Awareness of COVID-19 Before and After Quarantine Based on Crowdsourced Data From Rabigh City, Saudi Arabia: A Cross-Sectional and Comparative Study. Front Public Health 2021;9:632024. [PMID: 33898375 DOI: 10.3389/fpubh.2021.632024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
364 İnce U, Duran HT. RELATIONSHIP OF LIVER ENZYME LEVELS WITH THE CLINICAL COURSE OF COVID-19.. [DOI: 10.1101/2021.03.29.21254559] [Reference Citation Analysis]
365 Shi S, Wang F, Li J, Li Y, Li W, Wu X, Kou S, Wu Y, Wang X, Pei C, Huang D, Qiu H, Wang P, Wang Z. The effect of Chinese herbal medicine on digestive system and liver functions should not be neglected in COVID-19: An updated systematic review and meta-analysis. IUBMB Life 2021;73:739-60. [PMID: 33725395 DOI: 10.1002/iub.2467] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
366 Qiu Y, Tan ND, Mao R. Reply. Gastroenterology 2021;160:1897-8. [PMID: 33453229 DOI: 10.1053/j.gastro.2021.01.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
367 Park J, Jung J, Kim H, Park C, Kim D, Lee J, Ryu H. COVID-19 Mimicking Acute Colitis. Korean J Med 2021;96:143-146. [DOI: 10.3904/kjm.2021.96.2.143] [Reference Citation Analysis]
368 Elhence A, Vaishnav M, Biswas S, Chauhan A, Anand A, Shalimar. Coronavirus Disease-2019 (COVID-19) and the Liver. J Clin Transl Hepatol 2021;9:247-55. [PMID: 34007807 DOI: 10.14218/JCTH.2021.00006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
369 Shehab M, Alrashed F, Shuaibi S, Alajmi D, Barkun A. Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis. BMJ Open Gastroenterol 2021;8:e000571. [PMID: 33664052 DOI: 10.1136/bmjgast-2020-000571] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]
370 Bavaro DF, Diella L, Fabrizio C, Sulpasso R, Bottalico IF, Calamo A, Santoro CR, Brindicci G, Bruno G, Mastroianni A, Buccoliero GB, Carbonara S, Lo Caputo S, Santantonio T, Monno L, Angarano G, Saracino A. Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study. Int J Infect Dis 2021;105:709-15. [PMID: 33722685 DOI: 10.1016/j.ijid.2021.03.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
371 Sokol H, Contreras V, Maisonnasse P, Desmons A, Delache B, Sencio V, Machelart A, Brisebarre A, Humbert L, Deryuter L, Gauliard E, Heumel S, Rainteau D, Dereuddre-Bosquet N, Menu E, Ho Tsong Fang R, Lamaziere A, Brot L, Wahl C, Oeuvray C, Rolhion N, Van Der Werf S, Ferreira S, Le Grand R, Trottein F. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota. Gut Microbes 2021;13:1-19. [PMID: 33685349 DOI: 10.1080/19490976.2021.1893113] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
372 Jeyashree K, Raju M, Ponnaiah M, Muthappan S, Rozario AGA, Raichel R, Jeris WL, Gangakhedkar RR, Murhekar MV. Self-reported and clinically identified loss of smell and taste among persons tested for COVID-19 in Chennai, southern India, July-August 2020: A cross sectional study. Clin Epidemiol Glob Health 2021;11:100718. [PMID: 33754133 DOI: 10.1016/j.cegh.2021.100718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
373 Vanella G, Capurso G, Burti C, Fanti L, Ricciardiello L, Souza Lino A, Boskoski I, Bronswijk M, Tyberg A, Krishna Kumar Nair G, Angeletti S, Mauro A, Zingone F, Oppong KW, de la Iglesia-Garcia D, Pouillon L, Papanikolaou IS, Fracasso P, Ciceri F, Rovere-Querini P, Tomba C, Viale E, Eusebi LH, Riccioni ME, van der Merwe S, Shahid H, Sarkar A, Yoo JWG, Dilaghi E, Speight RA, Azzolini F, Buttitta F, Porcari S, Petrone MC, Iglesias-Garcia J, Savarino EV, Di Sabatino A, Di Giulio E, Farrell JJ, Kahaleh M, Roelandt P, Costamagna G, Artifon ELA, Bazzoli F, Testoni PA, Greco S, Arcidiacono PG. Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study. BMJ Open Gastroenterol 2021;8:e000578. [PMID: 33627313 DOI: 10.1136/bmjgast-2020-000578] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
374 Brogna B, Bignardi E, Brogna C, Volpe M, Lombardi G, Rosa A, Gagliardi G, Capasso PFM, Gravino E, Maio F, Pane F, Picariello V, Buono M, Colucci L, Musto LA. A Pictorial Review of the Role of Imaging in the Detection, Management, Histopathological Correlations, and Complications of COVID-19 Pneumonia. Diagnostics (Basel) 2021;11:437. [PMID: 33806423 DOI: 10.3390/diagnostics11030437] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
375 Skladany L, Koller T, Adamcova Selcanova S, Vnencakova J, Jancekova D, Durajova V, Laffers L, Svac J, Janickova K, Palkovič M, Kohout P, Golubnitschaja O. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J 2021;:1-14. [PMID: 33680218 DOI: 10.1007/s13167-021-00231-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
376 Shafran N, Issachar A, Shochat T, Shafran IH, Bursztyn M, Shlomai A. Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities. JHEP Rep 2021;3:100258. [PMID: 33644724 DOI: 10.1016/j.jhepr.2021.100258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
377 Jena A, Kumar-M P, Singh AK, Sharma V. Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic. Dig Liver Dis 2021;53:295-7. [PMID: 33132062 DOI: 10.1016/j.dld.2020.10.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
378 Marasco G, Lenti MV, Cremon C, Barbaro MR, Stanghellini V, Di Sabatino A, Barbara G. Implications of SARS-CoV-2 infection for neurogastroenterology. Neurogastroenterol Motil 2021;33:e14104. [PMID: 33591607 DOI: 10.1111/nmo.14104] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
379 Makar M, Minacapelli CD, Gupta K, Bhurwal A, Li Y, Catalano C, Bareket R, Jo S, Chouthai AA, Rustgi V. Gastrointestinal Manifestations and Liver Injury: Correlation with Mortality and Clinical Outcomes in Patients with COVID-19. EMJ Hepatol 2021. [DOI: 10.33590/emjhepatol/20-00233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
380 Wurth R, Hajdenberg M, Barrera FJ, Shekhar S, Copacino CE, Moreno-Peña PJ, Gharib OAM, Porter F, Hiremath S, Hall JE, Schiffrin EL, Eisenhofer G, Bornstein SR, Brito JP, González-González JG, Stratakis CA, Rodríguez-Gutiérrez R, Hannah-Shmouni F. Scoping review of COVID-19-related systematic reviews and meta-analyses: can we really have confidence in their results? Postgrad Med J 2021:postgradmedj-2020-139392. [PMID: 33637639 DOI: 10.1136/postgradmedj-2020-139392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
381 McCall LI. Quo vadis? Central Rules of Pathogen and Disease Tropism. Front Cell Infect Microbiol 2021;11:640987. [PMID: 33718287 DOI: 10.3389/fcimb.2021.640987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
382 Puoti MG, Rybak A, Kiparissi F, Gaynor E, Borrelli O. SARS-CoV-2 and the Gastrointestinal Tract in Children. Front Pediatr 2021;9:617980. [PMID: 33692973 DOI: 10.3389/fped.2021.617980] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
383 Cao C, Lakshminarayanan R, McCracken J, Lai J. Ampullitis Superimposed Obstructive Jaundice in a Patient With COVID-19. Gastroenterology Res 2021;14:41-4. [PMID: 33737998 DOI: 10.14740/gr1353] [Reference Citation Analysis]
384 Bleilevens C, Soppert J, Hoffmann A, Breuer T, Bernhagen J, Martin L, Stiehler L, Marx G, Dreher M, Stoppe C, Simon TP. Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study. Diagnostics (Basel) 2021;11:332. [PMID: 33671433 DOI: 10.3390/diagnostics11020332] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
385 Nabil A, Elshemy MM, Uto K, Soliman R, Hassan AA, Shiha G, Ebara M. Coronavirus (SARS-CoV-2) in gastroenterology and its current epidemiological situation: An updated review until January 2021. EXCLI J 2021;20:366-85. [PMID: 33746667 DOI: 10.17179/excli2021-3417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
386 Maslennikov R, Poluektova E, Ivashkin V, Svistunov A. Diarrhoea in adults with coronavirus disease-beyond incidence and mortality: a systematic review and meta-analysis. Infect Dis (Lond) 2021;53:348-60. [PMID: 33583306 DOI: 10.1080/23744235.2021.1885733] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
387 Schönfeld D, Arias S, Bossio JC, Fernández H, Gozal D, Pérez-Chada D. Clinical presentation and outcomes of the first patients with COVID-19 in Argentina: Results of 207079 cases from a national database. PLoS One 2021;16:e0246793. [PMID: 33571300 DOI: 10.1371/journal.pone.0246793] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
388 Bousquet J, Czarlewski W, Zuberbier T, Mullol J, Blain H, Cristol JP, De La Torre R, Pizarro Lozano N, Le Moing V, Bedbrook A, Agache I, Akdis CA, Canonica GW, Cruz AA, Fiocchi A, Fonseca JA, Fonseca S, Gemicioğlu B, Haahtela T, Iaccarino G, Ivancevich JC, Jutel M, Klimek L, Kraxner H, Kuna P, Larenas-Linnemann DE, Martineau A, Melén E, Okamoto Y, Papadopoulos NG, Pfaar O, Regateiro FS, Reynes J, Rolland Y, Rouadi PW, Samolinski B, Sheikh A, Toppila-Salmi S, Valiulis A, Choi HJ, Kim HJ, Anto JM. Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19. Int Arch Allergy Immunol 2021;182:324-38. [PMID: 33567446 DOI: 10.1159/000514204] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
389 Tung ML, Tan B, Cherian R, Chandra B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol Adv Pract 2021;5:rkaa081. [PMID: 33615129 DOI: 10.1093/rap/rkaa081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
390 Tsutsumi T, Saito M, Nagai H, Yamamoto S, Ikeuchi K, Lim LA, Adachi E, Koga M, Okushin K, Akai H, Kunimatsu A, Yotsuyanagi H. Association of coagulopathy with liver dysfunction in patients with COVID-19. Hepatol Res 2021;51:227-32. [PMID: 33047431 DOI: 10.1111/hepr.13577] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
391 Rueda Ruzafa L, Cedillo JL, Hone AJ. Nicotinic Acetylcholine Receptor Involvement in Inflammatory Bowel Disease and Interactions with Gut Microbiota. Int J Environ Res Public Health 2021;18:1189. [PMID: 33572734 DOI: 10.3390/ijerph18031189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
392 Lopes-Pacheco M, Silva PL, Cruz FF, Battaglini D, Robba C, Pelosi P, Morales MM, Caruso Neves C, Rocco PRM. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies. Front Physiol 2021;12:593223. [PMID: 33584343 DOI: 10.3389/fphys.2021.593223] [Cited by in Crossref: 46] [Cited by in F6Publishing: 55] [Article Influence: 23.0] [Reference Citation Analysis]
393 Al Mahruqi G, Stephen E, Abdelhedy I, Al Wahaibi K. Our early experience with mesenteric ischemia in COVID-19 positive patients. Ann Vasc Surg 2021;73:129-32. [PMID: 33508450 DOI: 10.1016/j.avsg.2021.01.064] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
394 Hatmi ZN. A Systematic Review of Systematic Reviews on the COVID-19 Pandemic. SN Compr Clin Med 2021;:1-18. [PMID: 33521564 DOI: 10.1007/s42399-021-00749-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
395 Gupta R, Kaushal V. Gastrointestinal and hepatic involvement in patients with SARS-CoV-2 infection. Arch Clin Gastroenterol 2021. [DOI: 10.17352/2455-2283.000089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
396 Furuyama W, Shifflett K, Pinski AN, Griffin AJ, Feldmann F, Okumura A, Gourdine T, Jankeel A, Lovaglio J, Hanley PW, Thomas T, Clancy CS, Messaoudi I, O'Donnell KL, Marzi A. Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine. bioRxiv 2021:2021. [PMID: 33501447 DOI: 10.1101/2021.01.19.426885] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
397 Li G, Yang Y, Gao D, Xu Y, Gu J, Liu P. Is liver involvement overestimated in COVID-19 patients? Int J Med Sci. 2021;18:1285-1296. [PMID: 33526990 DOI: 10.7150/ijms.51174] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
398 An X, Zhang Y, Duan L, Jin, Zhao S, Zhou R, Duan Y, Lian F, Tong X. The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19. Biomed Pharmacother 2021;137:111267. [PMID: 33508618 DOI: 10.1016/j.biopha.2021.111267] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 15.0] [Reference Citation Analysis]
399 Romano-Keeler J, Fiszbein D, Zhang J, Horowitz J, Hayani K, Buhimschi I, Lopez C, Kadhem Z, Berman J, Rasamimari P, Raghavan A, Pillers DM, Sun J. Center-Based Experiences Implementing Strategies to Reduce Risk of Horizontal Transmission of SARS-Cov-2: Potential for Compromise of Neonatal Microbiome Assemblage. medRxiv 2021:2021. [PMID: 33442705 DOI: 10.1101/2021.01.07.21249418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
400 Garrido M, Pereira Guedes T, Alves Silva J, Falcão D, Novo I, Archer S, Rocha M, Maia L, Sarmento-Castro R, Pedroto I. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19. GE Port J Gastroenterol 2021;158:1-12. [PMID: 34192127 DOI: 10.1159/000513593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
401 Gupta V, Mohsen W, Chapman TP, Satsangi J. Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021. J Crohns Colitis 2021;15:1211-21. [PMID: 33388777 DOI: 10.1093/ecco-jcc/jjaa265] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
402 Marins TA, Marra AR, Edmond MB, Colombo LRP, Vieira SF, de Oliveira Xavier F, Chauvin AG, Pinho JRR, de Almeida SM, Junior MSD. Adverse drug reactions and drug interactions in the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19). ASHE 2021;1:e38. [DOI: 10.1017/ash.2021.196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
403 Rajakumar AS, Green SR, Lokesh S, Venkatesh P, Gowtham V. Non-Respiratory Manifestations of COVID-19 and Pathophysiological Evidences. NEMJ 2021;2:8-12. [DOI: 10.2174/0250688203666210111152702] [Reference Citation Analysis]
404 Bartha FA, Karsai J, Tekeli T, Röst G. Symptom-Based Testing in a Compartmental Model of Covid-19. Infosys Science Foundation Series 2021. [DOI: 10.1007/978-981-16-2450-6_16] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
405 Denue B, Sepu N. Persistent vomiting as a manifestation of coronavirus disease-2019. Niger J Med 2021;30:218. [DOI: 10.4103/njm.njm_22_21] [Reference Citation Analysis]
406 Denue B, Ngamariju S, Abdul H, Musa A. Clinical characteristics of COVID-19 in a tertiary health facility in northeast Nigeria. Niger J Med 2021;30:334. [DOI: 10.4103/njm.njm_19_21] [Reference Citation Analysis]
407 Weldon C, James B, Jinnett K, Solon C, Thesing C, Fleurimont J, Watson K, Trosman J. 4R COVID-19 Toolkit for Patient Self-Management of Mild or Moderate COVID-19 symptoms. SSRN Journal. [DOI: 10.2139/ssrn.3773930] [Reference Citation Analysis]
408 Matković Z, Đekić-matković N. Ogilvie syndrome in a COVID-19 patient with pneumonia, absolute tachyarrhythmia and heart failure: A case report. Scripta Medica 2021;52:160-4. [DOI: 10.5937/scriptamed52-31646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
409 Grossi E, Pace F. Guidelines for the Perplexed: How to Maximize Colonoscopy Efficiency During the COVID-19 Pandemic. Dig Dis Sci 2021;66:2473-4. [PMID: 33001345 DOI: 10.1007/s10620-020-06634-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
410 Mendes JJ, Paiva JA, Gonzalez F, Mergulhão P, Froes F, Roncon R, Gouveia J. Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine. Rev Bras Ter Intensiva 2022;33:487-536. [PMID: 35081236 DOI: 10.5935/0103-507X.0103-507X-rbti-20210080] [Reference Citation Analysis]
411 Farooqui AA. Contribution of gut microbiota and multiple organ failure in the pathogenesis of COVID-19 infection. Gut Microbiota in Neurologic and Visceral Diseases 2021. [DOI: 10.1016/b978-0-12-821039-0.00014-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
412 Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. [PMID: 33692570 DOI: 10.1038/s41575-021-00426-4] [Cited by in Crossref: 149] [Cited by in F6Publishing: 143] [Article Influence: 74.5] [Reference Citation Analysis]
413 Midha V, Jindal J, Kaushal V, Sobti RC, Gupta R. COVID-19: Clinical Spectrum—It’s Multiorgan Syndrome. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications 2021. [DOI: 10.1007/978-981-16-5105-2_8] [Reference Citation Analysis]
414 Ong J, Dan YY. GI-COVID: Are There COVID-19 Patients with Primary Gastrointestinal SARS-CoV-2 Infection and Symptoms? Dig Dis Sci 2021;66:3228-30. [PMID: 33428034 DOI: 10.1007/s10620-020-06767-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
415 Penninger JM, Grant MB, Sung JJY. The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection. Gastroenterology 2021;160:39-46. [PMID: 33130103 DOI: 10.1053/j.gastro.2020.07.067] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 26.5] [Reference Citation Analysis]
416 Mendizabal M, Piñero F, Ridruejo E, Anders M, Silveyra MD, Torre A, Montes P, Urzúa A, Pages J, Toro LG, Díaz J, Gonzalez Ballerga E, Miranda-Zazueta G, Peralta M, Gutiérrez I, Michelato D, Venturelli MG, Varón A, Vera-Pozo E, Tagle M, García M, Tassara A, Brutti J, Ruiz García S, Bustios C, Escajadillo N, Macias Y, Higuera-de la Tijera F, Gómez AJ, Dominguez A, Castillo-Barradas M, Contreras F, Scarpin A, Schinoni MI, Toledo C, Girala M, Mainardi V, Sanchez A, Bessone F, Rubinstein F, Silva MO. Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission. Ann Hepatol 2021;21:100298. [PMID: 33359234 DOI: 10.1016/j.aohep.2020.100298] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
417 Lopez-Mendez I, Aquino-Matus J, Gall SM, Prieto-Nava JD, Juarez-Hernandez E, Uribe M, Castro-Narro G. Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19). Ann Hepatol 2021;20:100271. [PMID: 33099028 DOI: 10.1016/j.aohep.2020.09.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 15.0] [Reference Citation Analysis]
418 Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF. COVID-19: Discovery, diagnostics and drug development. J Hepatol 2021;74:168-84. [PMID: 33038433 DOI: 10.1016/j.jhep.2020.09.031] [Cited by in Crossref: 183] [Cited by in F6Publishing: 190] [Article Influence: 91.5] [Reference Citation Analysis]
419 Vespa E, Pugliese N, Colapietro F, Aghemo A. Stay (GI) Healthy: COVID-19 and Gastrointestinal Manifestations. Tech Innov Gastrointest Endosc 2021;23:179-89. [PMID: 33521703 DOI: 10.1016/j.tige.2021.01.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
420 Baiu I, Forgó E, Kin C, Weiser TG. Cec and You Shall Find: Cecal Perforation in a Patient with COVID-19. Dig Dis Sci 2021;66:3731-4. [PMID: 33492532 DOI: 10.1007/s10620-020-06810-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
421 Miranda-novales MG, Montaño-luna V, Aragón-nogales R. Basic information on COVID-19 pandemic, due to SARS-Cov-2 Virus. anal juríd - político 2020;2:29-47. [DOI: 10.22490/26655489.4361] [Reference Citation Analysis]
422 Rehman MFU, Fariha C, Anwar A, Shahzad N, Ahmad M, Mukhtar S, Farhan Ul Haque M. Novel coronavirus disease (COVID-19) pandemic: A recent mini review. Comput Struct Biotechnol J 2021;19:612-23. [PMID: 33398233 DOI: 10.1016/j.csbj.2020.12.033] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 8.7] [Reference Citation Analysis]
423 Cheranev V, Bulusheva I, Vechorko V, Korostin D, Rebrikov D. THE SEARCH FOR AN ASSOCIATION OF HLA ALLELES AND COVID-19 RELATED MORTALITY IN THE RUSSIAN POPULATION.. [DOI: 10.1101/2020.12.22.20248695] [Reference Citation Analysis]
424 Karimi L, Sales C, Crewther SG, Wijeratne T. Acute Ischemic Stroke in SARS-CoV, MERS-CoV, SARS-CoV-2: Neurorehabilitation Implications of Inflammation Induced Immunological Responses Affecting Vascular Systems. Front Neurol 2020;11:565665. [PMID: 33414753 DOI: 10.3389/fneur.2020.565665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
425 Ortega MA, Fraile-Martínez O, García-Montero C, García-Gallego S, Sánchez-Trujillo L, Torres-Carranza D, Álvarez-Mon MÁ, Pekarek L, García-Honduvilla N, Bujan J, Álvarez-Mon M, Asúnsolo Á, De la Torre B. An integrative look at SARS‑CoV‑2 (Review). Int J Mol Med 2021;47:415-34. [PMID: 33416095 DOI: 10.3892/ijmm.2020.4828] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
426 Hussein NR, Musa DH, Naqid IA, Sidiq M.saleem Z, Ibrahim N. The First Case of COVID-19 Reinfection in Duhok City, Kurdistan Region of Iraq: A Case Report. J Kermanshah Univ Med Sci 2020;24. [DOI: 10.5812/jkums.111454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
427 Kenes MT, McSparron JI, Marshall VD, Renius K, Hyzy RC. Propofol-Associated Hypertriglyceridemia in Coronavirus Disease 2019 Versus Noncoronavirus Disease 2019 Acute Respiratory Distress Syndrome. Crit Care Explor 2020;2:e0303. [PMID: 33354676 DOI: 10.1097/CCE.0000000000000303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
428 Hanafy AS, Abd-Elsalam S. Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective. World J Gastroenterol 2020; 26(46): 7272-7286 [PMID: 33362383 DOI: 10.3748/wjg.v26.i46.7272] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
429 Jakhmola S, Indari O, Kashyap D, Varshney N, Rani A, Sonkar C, Baral B, Chatterjee S, Das A, Kumar R, Jha HC. Recent updates on COVID-19: A holistic review. Heliyon 2020;6:e05706. [PMID: 33324769 DOI: 10.1016/j.heliyon.2020.e05706] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
430 Coveney C, Tellier M, Lu F, Maleki-Toyserkani S, Jones R, Bart VMT, Pring E, Alrubayyi A, Richter FC, Scourfield DO, Rehwinkel J, Rodrigues PRS, Davies LC, Gea-Mallorquí E; Oxford-Cardiff COVID19 Literature Consortium. Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion. Oxf Open Immunol 2020;1:iqaa004. [PMID: 34192267 DOI: 10.1093/oxfimm/iqaa004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
431 Cardinale V, Capurso G, Ianiro G, Gasbarrini A, Arcidiacono PG, Alvaro D. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis. Dig Liver Dis 2020;52:1383-9. [PMID: 33023827 DOI: 10.1016/j.dld.2020.09.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 15.0] [Reference Citation Analysis]
432 Mohandas S, Vairappan B. Severe acute respiratory syndrome coronavirus-2 infection and the gut-liver axis. J Dig Dis 2020;21:687-95. [PMID: 33099897 DOI: 10.1111/1751-2980.12951] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
433 Santana GO, de Santana AC, Pfeilsticker VB. Ileum Perforation in Crohn's Disease Patient During SARS-Cov-2 Infection. Inflamm Bowel Dis 2021;27:e42. [PMID: 33252125 DOI: 10.1093/ibd/izaa319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
434 Ahmed AR, Ebad CA, Stoneman S, Satti MM, Conlon PJ. Kidney injury in COVID-19. World J Nephrol 2020; 9(2): 18-32 [PMID: 33312899 DOI: 10.5527/wjn.v9.i2.18] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
435 Bang CS. Clinical Implication of Gastrointestinal and Liver Manifestations in the COVID-19 Pandemic Era. Korean J Gastroenterol 2020;76:268-271. [DOI: 10.4166/kjg.2020.137] [Reference Citation Analysis]
436 Silva FAFD, Brito BB, Santos MLC, Marques HS, Silva Júnior RTD, Carvalho LS, Vieira ES, Oliveira MV, Melo FF. COVID-19 gastrointestinal manifestations: a systematic review. Rev Soc Bras Med Trop 2020;53:e20200714. [PMID: 33263693 DOI: 10.1590/0037-8682-0714-2020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
437 Li J, Yue J, Zhang S, Wu J, Lian R, Zhang R, Cheng P. Relationship between digestive diseases and COVID-19 severity and mortality: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e23353. [PMID: 33235103 DOI: 10.1097/MD.0000000000023353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
438 Sarkesh A, Daei Sorkhabi A, Sheykhsaran E, Alinezhad F, Mohammadzadeh N, Hemmat N, Bannazadeh Baghi H. Extrapulmonary Clinical Manifestations in COVID-19 Patients. Am J Trop Med Hyg 2020;103:1783-96. [PMID: 32940201 DOI: 10.4269/ajtmh.20-0986] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 9.3] [Reference Citation Analysis]
439 Dorrell RD, Dougherty MK, Barash EL, Lichtig AE, Clayton SB, Jensen ET. Gastrointestinal and hepatic manifestations of COVID-19: A systematic review and meta-analysis. JGH Open 2020. [PMID: 33363257 DOI: 10.1002/jgh3.12456] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
440 Chadalavada P, Padbidri V, Garg R, Alomari M, Babar A, Kewan T, Ahuja KR, Contreras J, Al-Jaghbeer MJ, Sanaka MR. Transaminases are Potential Biomarkers of Disease Severity in COVID-19 Patients: A Single-Center Experience. Cureus 2020;12:e11555. [PMID: 33365223 DOI: 10.7759/cureus.11555] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
441 Boettcher AN, Hammoud DA, Weinberg JB, Agarwal P, Mendiratta-Lala M, Luker GD. Cancer Imaging and Patient Care during the COVID-19 Pandemic.Radiol Imaging Cancer. 2020;2:e200058. [PMID: 33778750 DOI: 10.1148/rycan.2020200058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
442 Tribolet L, Alexander MR, Brice AM, van Vuren PJ, Rootes CL, Mara K, Mcdonald M, Bruce KL, Gough TJ, Shi S, Cowled C, Bean AGD, Stewart CR. ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.. [DOI: 10.1101/2020.11.13.381343] [Reference Citation Analysis]
443 Váncsa S, Hegyi PJ, Zádori N, Szakó L, Vörhendi N, Ocskay K, Földi M, Dembrovszky F, Dömötör ZR, Jánosi K, Rakonczay Z Jr, Hartmann P, Horváth T, Erőss B, Kiss S, Szakács Z, Németh D, Hegyi P, Pár G. Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review. Front Med (Lausanne) 2020;7:572115. [PMID: 33282888 DOI: 10.3389/fmed.2020.572115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
444 Chen R, Yu YL, Li W, Liu Y, Lu JX, Chen F, Zhou Q, Xia ZY, Gao L, Meng QT, Ma D. Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective Study. Front Med (Lausanne) 2020;7:608259. [PMID: 33262996 DOI: 10.3389/fmed.2020.608259] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
445 Akin H, Kurt R, Tufan F, Swi A, Ozaras R, Tahan V, Hammoud G. Newly Reported Studies on the Increase in Gastrointestinal Symptom Prevalence withCOVID-19 Infection: A Comprehensive Systematic Review and Meta-Analysis. Diseases 2020;8:E41. [PMID: 33182651 DOI: 10.3390/diseases8040041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
446 Emmanuel N, Zibara V, Saad JM, Iskandar R, Abi Assaad R, Ammanouil E, Bilen Y, Chidiac G, El Ahmar N. COVID-19: What We Know So Far. Int J Clin Res 2020;1:73-108. [DOI: 10.38179/ijcr.v1i1.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
447 Janik E, Ceremuga M, Niemcewicz M, Bijak M. Dangerous Pathogens as a Potential Problem for Public Health. Medicina (Kaunas) 2020;56:E591. [PMID: 33172013 DOI: 10.3390/medicina56110591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
448 Li W, Yang S, Xu P, Zhang D, Tong Y, Chen L, Jia B, Li A, Ru D, Zhang B, Liu M, Lian C, Chen C, Fu W, Yuan S, Ren X, Liang Y, Yang Z, Li W, Wang S, Zhang X, Lu H, Xu J, Wang H, Yu W. Human Identical Sequences of SARS-CoV-2 Promote Clinical Progression of COVID-19 by Upregulating Hyaluronan via NamiRNA-Enhancer Network.. [DOI: 10.1101/2020.11.04.361576] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
449 Kaneko S, Kurosaki M, Nagata K, Taki R, Ueda K, Hanada S, Takayama K, Suzaki S, Harada N, Sugiyama T, Nagasawa M, Izumi N. Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity. PLoS One. 2020;15:e0241663. [PMID: 33147270 DOI: 10.1371/journal.pone.0241663] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
450 Wu ZH, Yang DL. A meta-analysis of the impact of COVID-19 on liver dysfunction. Eur J Med Res. 2020;25:54. [PMID: 33148326 DOI: 10.1186/s40001-020-00454-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
451 Sonkar C, Kashyap D, Varshney N, Baral B, Jha HC. Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach. SN Compr Clin Med 2020;:1-12. [PMID: 33169110 DOI: 10.1007/s42399-020-00619-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
452 Wu ZH, Yang DL. A meta-analysis of the impact of COVID-19 on liver dysfunction. Eur J Med Res 2020;25:54. [PMID: 33148326 DOI: 10.1186/s40001-020-00454-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 6.7] [Reference Citation Analysis]
453 Bertolini A, van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F, Fiorotto R, Jonker JW, Strazzabosco M, Verkade HJ, Peserico G. Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis. Hepatology 2020;72:1864-72. [PMID: 32702162 DOI: 10.1002/hep.31480] [Cited by in Crossref: 156] [Cited by in F6Publishing: 156] [Article Influence: 52.0] [Reference Citation Analysis]
454 D'Amico F, Danese S, Peyrin-Biroulet L. Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock. Clin Gastroenterol Hepatol 2020;18:2689-700. [PMID: 32777550 DOI: 10.1016/j.cgh.2020.08.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 12.0] [Reference Citation Analysis]
455 Muhanna D, Arnipalli SR, Kumar SB, Ziouzenkova O. Osmotic Adaptation by Na+-Dependent Transporters and ACE2: Correlation with Hemostatic Crisis in COVID-19. Biomedicines 2020;8:E460. [PMID: 33142989 DOI: 10.3390/biomedicines8110460] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
456 Hoiland RL, Fergusson NA, Mitra AR, Griesdale DEG, Devine DV, Stukas S, Cooper J, Thiara S, Foster D, Chen LYC, Lee AYY, Conway EM, Wellington CL, Sekhon MS. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Adv 2020;4:4981-9. [PMID: 33057633 DOI: 10.1182/bloodadvances.2020002623] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 27.7] [Reference Citation Analysis]
457 Zhang XS, Duchaine C. SARS-CoV-2 and Health Care Worker Protection in Low-Risk Settings: a Review of Modes of Transmission and a Novel Airborne Model Involving Inhalable Particles. Clin Microbiol Rev 2020;34:e00184-20. [PMID: 33115724 DOI: 10.1128/CMR.00184-20] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
458 Batista DV, Vieira CAFA, Costa TA, Lima EG. COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report. Diabetol Int 2020;:1-4. [PMID: 33133998 DOI: 10.1007/s13340-020-00473-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
459 Vrillon A, Hourregue C, Azuar J, Grosset L, Boutelier A, Tan S, Roger M, Mourman V, Mouly S, Sène D, François V, Dumurgier J, Paquet C; for LRB COVID Group. COVID-19 in Older Adults: A Series of 76 Patients Aged 85 Years and Older with COVID-19. J Am Geriatr Soc 2020;68:2735-43. [PMID: 33045106 DOI: 10.1111/jgs.16894] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
460 Shafran N, Issachar A, Shochat T, Shafran IH, Bursztyn M, Shlomai A. Abnormal liver tests in admitted patients with SARS-Cov-2 or other respiratory viruses- prognostic similarities and temporal disparities.. [DOI: 10.1101/2020.10.23.20218230] [Reference Citation Analysis]
461 Ibrahim YS, Karuppasamy G, Parambil JV, Alsoub H, Al-Shokri SD. Case Report: Paralytic Ileus: A Potential Extrapulmonary Manifestation of Severe COVID-19. Am J Trop Med Hyg. 2020;103:1600-1603. [PMID: 32876011 DOI: 10.4269/ajtmh.20-0894] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
462 Toor SM, Saleh R, Sasidharan Nair V, Taha RZ, Elkord E. T-cell responses and therapies against SARS-CoV-2 infection. Immunology 2021;162:30-43. [PMID: 32935333 DOI: 10.1111/imm.13262] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 27.7] [Reference Citation Analysis]
463 Moura DTH, Proença IM, McCarty TR, Sagae VMT, Ribeiro IB, Oliveira GHP, Souza GMV, Hirsch BS, Scatimburgo MVCV, Thompson CC, Carrilho FJ, Cecconello I, Moura EGH. Gastrointestinal Manifestations and Associated Health Outcomes of COVID-19: A Brazilian Experience From the Largest South American Public Hospital. Clinics (Sao Paulo) 2020;75:e2271. [PMID: 33146362 DOI: 10.6061/clinics/2020/e2271] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
464 Carvalho Laureano IC, Cabral Cavalcanti AF, Cavalcanti AL. Clinical Trials Developed in Brazil on Covid-19: What Is Being Researched? Shiraz E-Med J 2020;21. [DOI: 10.5812/semj.109059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
465 Wu M, Chen Y, Xia H, Wang C, Tan CY, Cai X, Liu Y, Ji F, Xiong P, Liu R, Guan Y, Duan Y, Kuang D, Xu S, Cai H, Xia Q, Yang D, Wang MW, Chiu IM, Cheng C, Ahern PP, Liu L, Wang G, Surana NK, Xia T, Kasper DL. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases. Proc Natl Acad Sci U S A 2020;117:28336-43. [PMID: 33082228 DOI: 10.1073/pnas.2018030117] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 31.7] [Reference Citation Analysis]
466 Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, Gao L, Ge MQ, Hung IFN, Ip MSM, Ip P, Lau KK, Lau CS, Lau LKW, Leung WK, Li X, Luo H, Man KKC, Ng VWS, Siu CW, Wan EYF, Wing YK, Wong CSM, Wong KHT, Wong ICK. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg Microbes Infect 2020;9:2190-9. [PMID: 32940572 DOI: 10.1080/22221751.2020.1825914] [Cited by in Crossref: 85] [Cited by in F6Publishing: 61] [Article Influence: 28.3] [Reference Citation Analysis]
467 Haischer MH, Beilfuss R, Hart MR, Opielinski L, Wrucke D, Zirgaitis G, Uhrich TD, Hunter SK. Who is wearing a mask? Gender-, age-, and location-related differences during the COVID-19 pandemic. PLoS One 2020;15:e0240785. [PMID: 33057375 DOI: 10.1371/journal.pone.0240785] [Cited by in Crossref: 206] [Cited by in F6Publishing: 232] [Article Influence: 68.7] [Reference Citation Analysis]
468 Hunt RH, East JE, Lanas A, Malfertheiner P, Satsangi J, Scarpignato C, Webb GJ. COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. Dig Dis 2021;39:119-39. [PMID: 33040064 DOI: 10.1159/000512152] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 15.0] [Reference Citation Analysis]
469 Penman SL, Kiy RT, Jensen RL, Beoku-Betts C, Alfirevic A, Back D, Khoo SH, Owen A, Pirmohamed M, Park BK, Meng X, Goldring CE, Chadwick AE. Safety perspectives on presently considered drugs for the treatment of COVID-19. Br J Pharmacol 2020;177:4353-74. [PMID: 32681537 DOI: 10.1111/bph.15204] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
470 Din S, Kent A, Pollok RC, Meade S, Kennedy NA, Arnott I, Beattie RM, Chua F, Cooney R, Dart RJ, Galloway J, Gaya DR, Ghosh S, Griffiths M, Hancock L, Hansen R, Hart A, Lamb CA, Lees CW, Limdi JK, Lindsay JO, Patel K, Powell N, Murray CD, Probert C, Raine T, Selinger C, Sebastian S, Smith PJ, Tozer P, Ustianowski A, Younge L, Samaan MA, Irving PM. Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel. Gut 2020;69:1769-77. [PMID: 32513653 DOI: 10.1136/gutjnl-2020-321927] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
471 Norsa L, Bonaffini PA, Indriolo A, Valle C, Sonzogni A, Sironi S. Poor Outcome of Intestinal Ischemic Manifestations of COVID-19. Gastroenterology 2020;159:1595-1597.e1. [PMID: 32569772 DOI: 10.1053/j.gastro.2020.06.041] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
472 Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, Chen N, Li A, Lu W, Chan FKL, Chan PKS, Ng SC. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. Gastroenterology 2020;159:1302-1310.e5. [PMID: 32598884 DOI: 10.1053/j.gastro.2020.06.048] [Cited by in Crossref: 142] [Cited by in F6Publishing: 149] [Article Influence: 47.3] [Reference Citation Analysis]
473 Miller J, Cantor A, Zachariah P, Ahn D, Martinez M, Margolis KG. Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases. Gastroenterology 2020;159:1571-1574.e2. [PMID: 32505742 DOI: 10.1053/j.gastro.2020.05.079] [Cited by in Crossref: 156] [Cited by in F6Publishing: 159] [Article Influence: 52.0] [Reference Citation Analysis]
474 Polat E, Erolu E, Ercan G, Boga A, Özgen İ, Yurdusever G, Göksu A, Güven Ş. Gastrointestinal System Involvement in Children suspected for COVID-19: A Single Tertiary Center Experience from Turkey. Online Türk Sağlık Bilimleri Dergisi 2020. [DOI: 10.26453/otjhs.757053] [Reference Citation Analysis]
475 Grinevich VB, Kravchuk YA, Ped VI, Sas EI, Salikova SP, Gubonina IV, Tkachenko EI, Sitkin SI, Lazebnik LB, Golovanova EV. Management of patients with digestive diseases during the COVID-19 pandemic: Clinical Practice Guidelines by the Gastroenterological Scientific Society of Russia. jour 2020. [DOI: 10.31146/1682-8658-ecg-179-7-4-51] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
476 Leist SR, Dinnon KH 3rd, Schäfer A, Tse LV, Okuda K, Hou YJ, West A, Edwards CE, Sanders W, Fritch EJ, Gully KL, Scobey T, Brown AJ, Sheahan TP, Moorman NJ, Boucher RC, Gralinski LE, Montgomery SA, Baric RS. A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. Cell 2020;183:1070-1085.e12. [PMID: 33031744 DOI: 10.1016/j.cell.2020.09.050] [Cited by in Crossref: 280] [Cited by in F6Publishing: 301] [Article Influence: 93.3] [Reference Citation Analysis]
477 Lee AC, Zhang AJ, Chan JF, Li C, Fan Z, Liu F, Chen Y, Liang R, Sridhar S, Cai JP, Poon VK, Chan CC, To KK, Yuan S, Zhou J, Chu H, Yuen KY. Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters. Cell Rep Med 2020;1:100121. [PMID: 32984855 DOI: 10.1016/j.xcrm.2020.100121] [Cited by in Crossref: 80] [Cited by in F6Publishing: 54] [Article Influence: 26.7] [Reference Citation Analysis]
478 Wang T, Smith DA, Campbell C, Harris S, Salih H, Várnai KA, Woods K, Noble T, Freeman O, Moysova Z, Marjot T, Webb GJ, Davies J, Barnes E, Matthews PC. Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID-19 patients as prognostic markers.. [DOI: 10.1101/2020.09.15.20194985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
479 Pathak SK, Pandey S, Pandey A, Salunke AA, Thivari P, Ratna HVK, Chawla J. Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection. Diabetes Metab Syndr 2020;14:1873-4. [PMID: 32998094 DOI: 10.1016/j.dsx.2020.09.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
480 Kimhofer T, Lodge S, Whiley L, Gray N, Loo RL, Lawler NG, Nitschke P, Bong SH, Morrison DL, Begum S, Richards T, Yeap BB, Smith C, Smith KGC, Holmes E, Nicholson JK. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection. J Proteome Res 2020;19:4442-54. [PMID: 32806897 DOI: 10.1021/acs.jproteome.0c00519] [Cited by in Crossref: 85] [Cited by in F6Publishing: 95] [Article Influence: 28.3] [Reference Citation Analysis]
481 Verstockt B, Verstockt S, Abdu Rahiman S, Ke BJ, Arnauts K, Cleynen I, Sabino J, Ferrante M, Matteoli G, Vermeire S. Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon. J Crohns Colitis 2021;15:485-98. [PMID: 32915959 DOI: 10.1093/ecco-jcc/jjaa185] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
482 Mark EG, Golden WC, Gilmore MM, Sick-Samuels A, Curless MS, Nogee LM, Milstone AM, Johnson J. Community-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Young Infants: A Systematic Review. J Pediatr 2021;228:94-100.e3. [PMID: 32910943 DOI: 10.1016/j.jpeds.2020.09.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
483 Grinevich VB, Gubonina IV, Doshchitsin VL, Kotovskaya YV, Kravchuk YA, Ped VI, Sas EI, Syrov AV, Tarasov AV, Tarzimanova AI, Tkacheva ON, Trukhan DI. Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020. Cardiovasc Ther Prev 2020;19:2630. [DOI: 10.15829/1728-8800-2020-2630] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 14.0] [Reference Citation Analysis]
484 Bernal-Monterde V, Casas-Deza D, Letona-Giménez L, de la Llama-Celis N, Calmarza P, Sierra-Gabarda O, Betoré-Glaria E, Martínez-de Lagos M, Martínez-Barredo L, Espinosa-Pérez M, M Arbones-Mainar J. SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization. Biomedicines 2020;8:E328. [PMID: 32899640 DOI: 10.3390/biomedicines8090328] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
485 Jin YH, Zhan QY, Peng ZY, Ren XQ, Yin XT, Cai L, Yuan YF, Yue JR, Zhang XC, Yang QW, Ji J, Xia J, Li YR, Zhou FX, Gao YD, Yu Z, Xu F, Tu ML, Tan LM, Yang M, Chen F, Zhang XJ, Zeng M, Zhu Y, Liu XC, Yang J, Zhao DC, Ding YF, Hou N, Wang FB, Chen H, Zhang YG, Li W, Chen W, Shi YX, Yang XZ, Wang XJ, Zhong YJ, Zhao MJ, Li BH, Ma LL, Zi H, Wang N, Wang YY, Yu SF, Li LY, Huang Q, Weng H, Ren XY, Luo LS, Fan MR, Huang D, Xue HY, Yu LX, Gao JP, Deng T, Zeng XT, Li HJ, Cheng ZS, Yao X, Wang XH; Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM)., Chinese Research Hospital Association (CRHA). Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version). Mil Med Res 2020;7:41. [PMID: 32887670 DOI: 10.1186/s40779-020-00270-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
486 Maev IV, Shpektor AV, Vasilyeva EY, Manchurov VN, Andreev DN. [Novel coronavirus infection COVID-19: extrapulmonary manifestations]. Ter Arkh 2020;92:4-11. [PMID: 33346454 DOI: 10.26442/00403660.2020.08.000767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
487 Bruce-Hickman D, Sajeed SM, Pang YH, Seow CS, Chen W, Gulati Kansal M. Bowel ulceration following tocilizumab administration in a COVID-19 patient. BMJ Open Gastroenterol 2020;7:e000484. [PMID: 32816957 DOI: 10.1136/bmjgast-2020-000484] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
488 Barrera FJ, González-González JG, Rodríguez-Gutiérrez R. Gastrointestinal and liver involvement in patients with COVID-19. Lancet Gastroenterol Hepatol 2020;5:799. [PMID: 32818458 DOI: 10.1016/S2468-1253(20)30209-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
489 Ponziani FR, Del Zompo F, Nesci A, Santopaolo F, Ianiro G, Pompili M, Gasbarrini A; “Gemelli against COVID-19” group. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients. Aliment Pharmacol Ther 2020;52:1060-8. [PMID: 32628793 DOI: 10.1111/apt.15996] [Cited by in Crossref: 24] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
490 Gaber Y. Diarrhoea and the COVID-19 pandemic. Arab J Gastroenterol 2020;21:146-50. [PMID: 32680695 DOI: 10.1016/j.ajg.2020.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
491 Takkar S, Jyotsna M, Goyal P, Chaudhary A, Vipperla S, Hemalatha Y, Midha V, John M, Kakollu A, Tandon P, Puri S, Anupama H, Priya G, Pinto B, Reddy VP, Irukulla MM, Takkar A, Kaur M, Karak S, Vegesna R, Chhina DK, Kapoor PM, Adapa S. Consensus Scientific Statement on Advisory Working Guidelines and Recommendations for the Female Population in COVID-19 Era by WINCARS. Indian Journal of Cardiovascular Disease in Women WINCARS 2020;5:175-194. [DOI: 10.1055/s-0040-1718607] [Reference Citation Analysis]
492 Ferm S, Fisher C, Pakala T, Tong M, Shah D, Schwarzbaum D, Cooley V, Hussain S, Kim SH. Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY. Clin Gastroenterol Hepatol 2020;18:2378-2379.e1. [PMID: 32497637 DOI: 10.1016/j.cgh.2020.05.049] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 15.0] [Reference Citation Analysis]
493 Tian Y, Rong L. Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with coronavirus disease 2019-authors' reply. Aliment Pharmacol Ther 2020;52:904-5. [PMID: 32852827 DOI: 10.1111/apt.15986] [Reference Citation Analysis]
494 Tan ND, Qiu Y, Xing XB, Ghosh S, Chen MH, Mao R. Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19. Gastroenterology 2020;159:1170-1172.e1. [PMID: 32422208 DOI: 10.1053/j.gastro.2020.05.034] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 15.7] [Reference Citation Analysis]
495 Anikhindi SA, Kumar A, Arora A. COVID-19 in patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2020;14:1187-93. [PMID: 32856955 DOI: 10.1080/17474124.2020.1816822] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
496 Wahab SF, Løgstrup BB. Atypical manifestations of COVID-19 in general practice: a case of gastrointestinal symptoms. BMJ Case Rep 2020;13:e237520. [PMID: 32859618 DOI: 10.1136/bcr-2020-237520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
497 Qiu Y, He JS, Tan JY, Lin SN, Mao R. Gastrointestinal and liver involvement in patients with COVID-19 - Authors' reply. Lancet Gastroenterol Hepatol 2020;5:799-800. [PMID: 32818457 DOI: 10.1016/S2468-1253(20)30240-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
498 Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA 2020;324:782-93. [PMID: 32648899 DOI: 10.1001/jama.2020.12839] [Cited by in Crossref: 2300] [Cited by in F6Publishing: 2479] [Article Influence: 766.7] [Reference Citation Analysis]
499 Xu Y, Liu P, Gu J. Gastrointestinal and liver involvement in patients with COVID-19. Lancet Gastroenterol Hepatol 2020;5:798-9. [PMID: 32818456 DOI: 10.1016/S2468-1253(20)30205-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
500 Guerra I, Algaba A, Jiménez L, Mar Aller M, Garza D, Bonillo D, Molina Esteban LM, Bermejo F. Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain. Inflamm Bowel Dis 2021;27:25-33. [PMID: 32830267 DOI: 10.1093/ibd/izaa221] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
501 Hasan MJ, Chowdhury SM, Khan MAS, Rahaman M, Fardous J, Adit T, Rahman M, Hossain MT, Yesmin S, Raheem E, Amin MR. Clinico-epidemiological characteristics of asymptomatic and symptomatic COVID-19-positive patients in Bangladesh.. [DOI: 10.1101/2020.08.18.20177089] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
502 Hassan AO, Kafai NM, Dmitriev IP, Fox JM, Smith BK, Harvey IB, Chen RE, Winkler ES, Wessel AW, Case JB, Kashentseva E, McCune BT, Bailey AL, Zhao H, VanBlargan LA, Dai YN, Ma M, Adams LJ, Shrihari S, Danis JE, Gralinski LE, Hou YJ, Schäfer A, Kim AS, Keeler SP, Weiskopf D, Baric RS, Holtzman MJ, Fremont DH, Curiel DT, Diamond MS. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell 2020;183:169-184.e13. [PMID: 32931734 DOI: 10.1016/j.cell.2020.08.026] [Cited by in Crossref: 276] [Cited by in F6Publishing: 298] [Article Influence: 92.0] [Reference Citation Analysis]
503 Shady A, Singh AP, Gbaje E, Oliva M, Golden-Espinal S, Macciola D, Soto D, Eddy WE, Adkoli A, Bergasa NV. Characterization of Patients with COVID-19 Admitted to a Community Hospital of East Harlem in New York City. Cureus 2020;12:e9836. [PMID: 32953343 DOI: 10.7759/cureus.9836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
504 Garland V, Kumar AB, Borum ML. Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations. J Natl Med Assoc. 2021;113:142-146. [PMID: 32807512 DOI: 10.1016/j.jnma.2020.07.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
505 Garg R, Jain R, Sodani A, Chouksey D, Dosi R, Athale S, Goyal N, Rathi P, Singh H, Telang K. Neurological Symptoms as Initial Manifestation of Covid-19 - An Observational Study. Ann Indian Acad Neurol 2020;23:482-6. [PMID: 33223664 DOI: 10.4103/aian.AIAN_560_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
506 Lu YF, Pan LY, Zhang WW, Cheng F, Hu SS, Zhang X, Jiang HY. A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19. Int J Infect Dis 2020;100:34-41. [PMID: 32798659 DOI: 10.1016/j.ijid.2020.08.023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 13.7] [Reference Citation Analysis]
507 Yokobori S. Heatstroke management during the COVID-19 epidemic: Recommendations from the experts in Japan. Acute Med Surg 2020. [PMID: 32837733 DOI: 10.1002/ams2.560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
508 Uchida Y, Uemura H, Yamaba S, Hamada D, Tarumoto N, Maesaki S, Mochida S. Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19. J Gastroenterol. 2020;55:1098-1106. [PMID: 32776161 DOI: 10.1007/s00535-020-01717-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
509 Frediansyah A, Nainu F, Dhama K, Mudatsir M, Harapan H. Remdesivir and its antiviral activity against COVID-19: A systematic review. Clin Epidemiol Glob Health 2021;9:123-7. [PMID: 32838064 DOI: 10.1016/j.cegh.2020.07.011] [Cited by in Crossref: 78] [Cited by in F6Publishing: 95] [Article Influence: 26.0] [Reference Citation Analysis]
510 Boettler T, Marjot T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Jalan R, Moreau R, Cornberg M, Berg T. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 mo of the pandemic. JHEP Rep. 2020;2:100169. [PMID: 32835190 DOI: 10.1016/j.jhepr.2020.100169] [Cited by in Crossref: 72] [Cited by in F6Publishing: 89] [Article Influence: 24.0] [Reference Citation Analysis]
511 Silva-Filho JC, Melo CGF, Oliveira JL. The influence of ABO blood groups on COVID-19 susceptibility and severity: A molecular hypothesis based on carbohydrate-carbohydrate interactions. Med Hypotheses 2020;144:110155. [PMID: 33254482 DOI: 10.1016/j.mehy.2020.110155] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
512 Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, Talukdar R, Sharma M, Qi X, Rao PN, Reddy DN. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther 2020;52:584-99. [PMID: 32638436 DOI: 10.1111/apt.15916] [Cited by in Crossref: 125] [Cited by in F6Publishing: 122] [Article Influence: 41.7] [Reference Citation Analysis]
513 Congiusta DV, Otero K, Ippolito J, Thomson J, Beebe KS. A new role for orthopaedic surgeons: ongoing changes, lessons learned, and perspectives from a level I trauma center during the COVID-19 pandemic. J Shoulder Elbow Surg 2020;29:1951-6. [PMID: 32738400 DOI: 10.1016/j.jse.2020.07.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
514 Fraser J, Mousley J, Testro A, Smibert OC, Koshy AN. Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis. Transplant Proc 2020;52:2676-83. [PMID: 32891405 DOI: 10.1016/j.transproceed.2020.07.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
515 Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Organ-specific manifestations of COVID-19 infection. Clin Exp Med 2020;20:493-506. [PMID: 32720223 DOI: 10.1007/s10238-020-00648-x] [Cited by in Crossref: 230] [Cited by in F6Publishing: 180] [Article Influence: 76.7] [Reference Citation Analysis]
516 Seeliger B, Philouze G, Cherkaoui Z, Felli E, Mutter D, Pessaux P. Acute abdomen in patients with SARS-CoV-2 infection or co-infection. Langenbecks Arch Surg 2020;405:861-6. [PMID: 32720012 DOI: 10.1007/s00423-020-01948-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
517 Ong CJ, Lim HJ, Tan JW, Wong JSM, Lim ST, Kwek JW, Tan HK, Hwang WYK, Chia CS. Facilitating timely cancer care in a surgical oncology subspecialty unit during the pandemic and recovery phase of the COVID era. Asian J Surg 2020;43:965-6. [PMID: 32713751 DOI: 10.1016/j.asjsur.2020.07.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
518 Neri P, Lamperti M, Pichi F. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models. Int Ophthalmol 2020;40:1879-83. [PMID: 32621017 DOI: 10.1007/s10792-020-01495-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
519 Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, Blomberg WR, Meigs DD, Hasan M, Patel M, Kline P, Chang RC, Chang L, Gendelman HE, Kevadiya BD. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J Neuroimmune Pharmacol. 2020;15:359-386. [PMID: 32696264 DOI: 10.1007/s11481-020-09944-5] [Cited by in Crossref: 236] [Cited by in F6Publishing: 189] [Article Influence: 78.7] [Reference Citation Analysis]
520 Hassan AO, Kafai NM, Dmitriev IP, Fox JM, Smith B, Harvey IB, Chen RE, Winkler ES, Wessel AW, Case JB, Kashentseva E, Mccune BT, Bailey AL, Zhao H, Vanblargan LA, Dai Y, Ma M, Adams LJ, Shrihari S, Gralinski LE, Hou YJ, Schaefer A, Kim AS, Keeler SP, Weiskopf D, Baric R, Holtzman MJ, Fremont DH, Curiel DT, Diamond MS. A single intranasal dose of chimpanzee adenovirus-vectored vaccine confers sterilizing immunity against SARS-CoV-2 infection.. [DOI: 10.1101/2020.07.16.205088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
521 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
522 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
523 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
524 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
525 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
526 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
527 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
528 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
529 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
530 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
531 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
532 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
533 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032. [PMID: 32651579 DOI: 10.1038/s41591-020-0968-3] [Cited by in Crossref: 1476] [Cited by in F6Publishing: 1550] [Article Influence: 492.0] [Reference Citation Analysis]
534 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
535 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
536 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
537 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
538 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
539 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
540 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
541 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
542 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
543 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
544 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
545 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
546 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
547 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
548 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
549 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
550 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
551 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
552 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
553 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
554 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
555 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
556 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
557 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
558 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
559 Elmunzer BJ, Spitzer RL, Foster LD, Merchant AA, Howard EF, Patel VA, West MK, Qayed E, Nustas R, Zakaria A, Piper MS, Taylor JR, Jaza L, Forbes N, Chau M, Lara LF, Papachristou GI, Volk ML, Hilson LG, Zhou S, Kushnir VM, Lenyo AM, Mcleod CG, Amin S, Kuftinec GN, Yadav D, Fox C, Kolb JM, Pawa S, Pawa R, Canakis A, Huang C, Jamil LH, Aneese AM, Glamour BK, Smith ZL, Hanley KA, Wood J, Patel HK, Shah JN, Agarunov E, Sethi A, Fogel EL, Mcnulty G, Haseeb A, Trieu JA, Dixon RE, Yang JY, Mendelsohn RB, Calo D, Aroniadis OC, Lacomb JF, Scheiman JM, Sauer BG, Dang DT, Piraka CR, Shah ED, Pohl H, Tierney WM, Mitchell S, Condon A, Lenhart A, Dua KS, Kanagala VS, Kamal A, Singh VK, Pinto-sanchez MI, Hutchinson JM, Kwon RS, Korsnes SJ, Singh H, Solati Z, Deshpande AR, Rockey DC, Alford TB, Durkalski V, the North American Alliance for the Study of Digestive Manifestations of COVID-19.. Digestive Manifestations in Patients Hospitalized with COVID-19.. [DOI: 10.1101/2020.07.07.20143024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
560 Li G, Xu Y, Yang YT, Liu PF. Prevalence of acute liver injury and hypertransaminemia in patients with COVID-19: a protocol for a systematic review. BMJ Open 2020;10:e040517. [PMID: 32641369 DOI: 10.1136/bmjopen-2020-040517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
561 Trottein F, Sokol H. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection. Cell Rep 2020;32:107915. [PMID: 32649864 DOI: 10.1016/j.celrep.2020.107915] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 29.0] [Reference Citation Analysis]
562 Tack J, Vanuytsel T, Serra J, Accarino A, Stanghellini V, Barbara G; ESNM Consensus Group, the Leuven Consensus Group, the Italian Consensus Group, the Spanish Consensus Group on function testing in the COVID-19 pandemic era. European Society for Neurogastroenterology and Motility recommendations for conducting gastrointestinal motility and function testing in the recovery phase of the COVID-19 pandemic. Neurogastroenterol Motil 2020;32:e13930. [PMID: 32525249 DOI: 10.1111/nmo.13930] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
563 Gupta R, Patnaik I, Kumar A. Letter to the editor in response to COVID-19 presenting as acute pancreatitis. Pancreatology 2020;20:1021-2. [PMID: 32651079 DOI: 10.1016/j.pan.2020.06.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
564 Tsibouris P, Ekmektzoglou K, Agorogianni A, Kalantzis C, Theofanopoulou A, Toumbelis K, Petrogiannopoulos L, Poutakidis C, Goggaki S, Braimakis I, Vlachou E, Pouliakis A, Apostolopoulos P. Gastrointestinal involvement in COVID-19 patients: a retrospective study from a Greek COVID-19 referral hospital. Ann Gastroenterol 2020;33:465-72. [PMID: 32879592 DOI: 10.20524/aog.2020.0514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
565 Verstockt B, Verstockt S, Rahiman SA, Ke B, Arnauts K, Cleynen I, Sabino J, Ferrante M, Matteoli G, Vermeire S. Intestinal receptor of SARS-CoV-2 in inflamed IBD tissue is downregulated by HNF4A in ileum and upregulated by interferon regulating factors in colon.. [DOI: 10.1101/2020.06.24.169383] [Reference Citation Analysis]
566 Su S, Shen J, Zhu L, Qiu Y, He JS, Tan JY, Iacucci M, Ng SC, Ghosh S, Mao R, Liang J. Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges. Therap Adv Gastroenterol 2020;13:1756284820934626. [PMID: 32595762 DOI: 10.1177/1756284820934626] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 12.7] [Reference Citation Analysis]
567 Aldhaleei WA, Alnuaimi A, Bhagavathula AS. COVID-19 Induced Hepatitis B Virus Reactivation: A Novel Case From the United Arab Emirates. Cureus. 2020;12:e8645. [PMID: 32550096 DOI: 10.7759/cureus.8645] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 6.7] [Reference Citation Analysis]
568 Tariq R, Saha S, Furqan F, Hassett L, Pardi D, Khanna S. Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis. Mayo Clin Proc. 2020;95:1632-1648. [PMID: 32753138 DOI: 10.1016/j.mayocp.2020.06.003] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 23.3] [Reference Citation Analysis]
569 Ling KL, Hilmi I, Raja Ali RA, Leong RWL, Leung WK, Ng SC, Wu KC, Chen MH, Ran ZH, Hisamatsu T, Ahuja V, Makharia GK, Banerjee R, Wei SC, Wu DC, Pisespongsa P, Ye BD, Sollano J, Simadibrata M, Chuah SW, Ooi CJ. Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic. JGH Open 2020;4:320-3. [PMID: 32514431 DOI: 10.1002/jgh3.12362] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
570 Seeliger B, Philouze G, Benotmane I, Mutter D, Pessaux P. Is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present intraperitoneally in patients with coronavirus disease 2019 (COVID-19) infection undergoing emergency operations? Surgery 2020;168:220-1. [PMID: 32591139 DOI: 10.1016/j.surg.2020.05.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
571 Liu M, Gao Y, Zhang Y, Shi S, Chen Y, Tian J. The association between severe or dead COVID-19 and autoimmune diseases: A systematic review and meta-analysis. J Infect 2020;81:e93-5. [PMID: 32502509 DOI: 10.1016/j.jinf.2020.05.065] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
572 Shetty SS, Merchant Y, Shabadi N, Aljunid ST. 10 "C" in COVID19. Oral Surg 2020. [PMID: 32837534 DOI: 10.1111/ors.12527] [Reference Citation Analysis]
573 Khan MA, Sivalingam A, Haller JA. Perceptions of Occupational Risk and Changes in Clinical Practice of United States Vitreoretinal Surgery Fellows during the COVID-19 Pandemic. Ophthalmol Retina 2020;4:1181-7. [PMID: 32450265 DOI: 10.1016/j.oret.2020.05.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
574 Yang L, Tu L. Implications of gastrointestinal manifestations of COVID-19. Lancet Gastroenterol Hepatol. 2020;5:629-630. [PMID: 32405602 DOI: 10.1016/s2468-1253(20)30132-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 45] [Article Influence: 21.0] [Reference Citation Analysis]
575 Nikonov E, Ivanikov I, Burakov A, Zharova M. COVID-19 and its influence on gastroenterology and endoscopy. Dok gastroenterol 2020;9:111. [DOI: 10.17116/dokgastro20209041111] [Reference Citation Analysis]
576 Ghoshal U, Vasanth S, Tejan N. A guide to laboratory diagnosis of Corona Virus Disease-19 for the gastroenterologists. Indian J Gastroenterol 2020;39:236-42. [PMID: 32875524 DOI: 10.1007/s12664-020-01082-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
577 Srivastava P, Gupta N. Clinical Manifestations of Corona Virus Disease. Clinical Synopsis of COVID-19 2020. [DOI: 10.1007/978-981-15-8681-1_3] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
578 Wong YJ, Tan M, Zheng Q, Li JW, Kumar R, Fock KM, Teo EK, Ang TL. A systematic review and meta-analysis of the COVID-19 associated liver injury. Ann Hepatol 2020;19:627-34. [PMID: 32882393 DOI: 10.1016/j.aohep.2020.08.064] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
579 Uribe M, Aquino-Matus J. Hepatology and the "new reality" ushered in by the COVID-19 pandemic. Ann Hepatol 2020;19:449-50. [PMID: 32891255 DOI: 10.1016/j.aohep.2020.08.060] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
580 Dhar J, Samanta J, Kochhar R. Corona Virus Disease-19 pandemic: The gastroenterologists' perspective. Indian J Gastroenterol 2020;39:220-31. [PMID: 32783168 DOI: 10.1007/s12664-020-01075-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
581 Leal-leyte P, Zamora-valdés D, Méndez-sánchez N. Enfermedad hepática y trasplante durante la pandemia COVID-19/SARS-CoV-2. Revista Mexicana de Trasplantes 2020;9:206-215. [DOI: 10.35366/94510] [Reference Citation Analysis]
582 Cázares de León F, Hernández Millán A, Pacheco González, Pacheco morffi P. Consideraciones sobre el diagnóstico de COVID-19 y el papel del diagnóstico salival. Revista de la Asociación Dental Mexicana 2020;77:191-196. [DOI: 10.35366/95112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
583 Rohani P, Ahmadi Badi S, Moshiri A, Siadat SD. Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology. Gastroenterol Hepatol Bed Bench 2020;13:351-4. [PMID: 33244377] [Reference Citation Analysis]
584 [DOI: 10.1101/2020.07.02.20144865] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Reference Citation Analysis]